tropism
immunopathogenesi
corrobor
similar
share
fiv
chapter
serv
overview
fiv
anim
model
hiv
aid
focu
fiv
molecular
biolog
virolog
address
recent
develop
fiv
viral
vector
develop
well
nondomest
fiv
biolog
fiv
pathogenesi
vaccin
develop
antivir
therapi
critic
topic
discuss
regard
valu
fiv
anim
model
also
describ
briefli
overview
examin
signific
detail
subsequ
chapter
morpholog
fiv
viru
particl
similar
lentivirus
matur
extracellular
virion
spheric
ellipsoid
nm
diamet
border
outer
envelop
poorli
defin
short
project
knob
elong
conic
shell
surround
eccentr
posit
electrondens
viral
nucleoid
polygon
electronluc
halo
often
visibl
core
granular
layer
locat
insid
envelop
similar
lentivirus
densiti
fiv
shown
gcm
continu
sucros
gradient
centrifug
typic
retrovirus
fiv
genom
consist
ident
pair
singlestrand
rna
molecul
approxim
base
length
dens
pack
within
virion
associ
nucleocapsid
protein
nc
trna
ly
hydrogenbond
rna
molecul
primer
bind
site
pb
locat
within
termin
base
genom
serv
primer
neg
strand
revers
transcript
ribonucleoprotein
complex
contain
within
protein
core
larg
compos
viral
capsid
protein
ca
associ
surround
roughli
spheric
shell
consist
myristyl
matrix
protein
also
contain
viral
capsid
viral
enzym
involv
particl
matur
replic
viral
rna
genom
includ
proteas
pr
revers
transcriptas
rt
integras
dutpas
du
nc
ca
express
gag
gene
pr
rt
du
product
pol
gene
outsid
matrix
coat
lipid
bilay
virion
envelop
confer
characterist
icosahedr
morpholog
envelop
retroviru
embed
within
lipid
bilay
viral
envelop
glycoprotein
transmembran
subunit
tm
present
singlepass
transmembran
protein
anchor
surfac
unit
su
entir
extravirion
protein
bound
tm
tm
su
product
env
gene
env
gene
product
mediat
bind
viru
cell
surfac
receptor
fusion
target
cell
membran
critic
target
host
humor
cellular
immun
respons
sequenc
organ
fiv
genom
similar
lentivirus
flank
two
long
termin
repeat
ltr
end
fiv
provir
dna
genom
contain
three
larg
open
read
frame
orf
gag
pol
env
encod
intern
structur
protein
rt
viral
enzym
envelop
protein
respect
well
variou
small
orf
encod
regulatori
accessori
protein
figur
fiv
genom
also
contain
nonencod
regulatori
sequenc
import
viru
replic
sequenc
includ
transcript
element
within
ltr
posttranscript
regulatori
sequenc
locat
half
genom
encapsid
determin
within
domain
first
nucleotid
gag
critic
noncod
sequenc
includ
central
polypurin
tract
cppt
involv
prime
plusstrand
dna
synthesi
central
termin
sequenc
ct
import
format
central
dna
flap
revers
transcript
approxim
bp
long
fiv
ltr
accommod
multipl
regulatori
sequenc
compos
three
domain
design
r
locat
terminu
provir
dna
genom
ltr
border
two
bpinvert
repeat
critic
transcript
regulatori
sequenc
locat
fiv
domain
consist
enhanc
element
includ
atf
also
known
camp
respons
element
cre
cebp
site
cisact
element
shown
import
fiv
ltr
promot
activ
vitro
viru
replic
vitro
vivo
previou
studi
also
demonstr
bind
specif
ltr
sequenc
cellular
protein
use
dnase
footprint
gel
shift
assay
although
cisact
transcript
element
within
fiv
domain
differ
describ
critic
hiv
ltr
nfkb
fivencod
atf
sequenc
posit
regulatori
element
respond
host
cell
activ
state
properti
also
share
nfkb
site
within
ltr
retrovirus
encod
ltr
regul
atfcreb
famili
transcript
factor
includ
human
tlymphotrop
viru
type
bovin
leukemia
viru
blv
similarli
site
encod
visna
viru
ltr
found
critic
basal
activ
transactiv
viral
ltr
result
interact
visna
viru
put
transcript
transactiv
tat
protein
cellular
transcript
factor
fo
jun
interestingli
structur
orfa
fiv
accessori
gene
product
previous
regard
tat
protein
similar
visna
viru
tat
collect
observ
suggest
fiv
ltr
promot
activ
may
regul
multipl
cell
activ
pathway
involv
possibl
interact
viral
accessori
protein
orfa
cellular
protein
bind
either
atf
cebp
element
howev
definit
character
potenti
interact
yet
report
knowledg
potenti
complex
interact
fiv
ltr
viral
cellular
protein
like
involv
regul
fiv
express
still
rudimentari
best
fiv
ltr
also
distinguish
ltr
strong
basal
promot
activ
requir
activ
viral
transactiv
similarli
anim
lentivirus
includ
caprin
arthriti
enceph
viru
caev
visna
viru
vv
also
encod
ltr
promot
capabl
high
basal
level
transcript
absenc
viral
transactiv
contrast
ltr
encod
primat
lentivirus
includ
hiv
simian
immunodefici
viru
siv
includ
transcript
element
design
tar
tat
respons
element
possess
stemloop
structur
bind
viru
encod
transactiv
tat
cellular
protein
tat
transactiv
hiv
ltr
requir
elong
initi
rna
transcript
effici
transcript
viral
gene
fiv
ltr
contain
stemloop
structur
similar
complex
fiv
encod
transcript
transactiv
structur
activ
similar
describ
hiv
tat
previou
report
propos
gene
product
fiv
accessori
gene
orfa
may
encod
viral
transactiv
fiv
tat
howev
studi
gener
conflict
data
regard
abil
fivencod
orfa
transactiv
fiv
ltr
reveal
either
effect
small
effect
moder
effect
impos
orfa
fiv
ltrdirect
gene
express
transient
express
assay
taken
togeth
data
suggest
fiv
ltr
may
regul
part
accessori
protein
orfa
although
mechan
unlik
describ
hiv
ltr
hiv
tat
examin
fiv
mrna
speci
infect
cell
reveal
presenc
least
five
short
multipli
splice
transcript
addit
unsplic
genom
rna
envcontain
singli
splice
transcript
nuclear
export
unsplic
singli
splice
fiv
mrna
transcript
involv
bind
posttranscript
regulatori
sequenc
design
rev
respons
element
rre
fiv
regulatori
protein
rev
fiv
rre
nucleotid
sequenc
form
stemloop
structur
within
viral
mrna
speci
serv
bind
site
fiv
regulatori
protein
rev
structur
function
similar
rre
howev
fiv
rre
locat
terminu
env
gene
partial
overlap
ltr
wherea
rre
posit
junction
su
tm
open
read
frame
within
env
bind
fiv
rre
viral
protein
rev
critic
cytoplasm
accumul
unsplic
singli
splice
fiv
mrna
transcript
fiv
structur
gag
env
enzymat
pol
protein
express
fiv
gag
protein
necessari
suffici
format
noninfecti
viruslik
particl
similar
lentiviru
system
express
fiv
gag
polyprotein
precursor
gag
gene
within
unsplic
genom
rna
depend
viral
rev
nevertheless
fiv
gag
polyprotein
express
absenc
viral
structur
protein
env
gene
product
capabl
selfassembl
viru
particl
releas
plasma
membran
gagexpress
cell
format
matur
viru
particl
howev
requir
cleavag
fiv
gag
polyprotein
virusencod
pr
shortli
bud
cell
gener
three
matur
gag
protein
ca
nc
figur
examin
proteolyt
site
within
fiv
gag
polyprotein
reveal
process
gag
protein
similar
gag
protein
particular
ca
protein
within
matur
virion
attach
viral
lipid
membran
ca
form
viru
core
nc
present
viru
core
ribonucleoprotein
complex
viral
rna
genom
report
describ
studi
focus
fiv
gag
protein
process
character
function
domain
still
limit
similar
hiv
myristyl
fiv
requir
target
plasma
membran
late
event
viral
assembl
contrast
observ
target
fiv
cellular
plasma
membran
depend
ntermin
polybas
domain
present
fiv
primat
lentiviru
protein
instead
conserv
polybas
domain
lysinerich
fiv
appear
necessari
either
particl
assembl
releas
role
fiv
step
viru
replic
thought
import
earli
postentri
event
yet
determin
princip
function
fiv
nc
involv
encapsid
fulllength
unsplic
viral
genom
rna
virion
similar
retrovirus
fiv
nc
protein
contain
two
copi
zinc
finger
motif
character
zincbind
moieti
rna
although
studi
describ
fiv
nc
interact
viral
rna
recent
observ
suggest
fiv
nc
bind
viral
rna
upstream
pb
may
therebi
initi
rna
dimer
promot
initi
minu
strand
dna
howev
role
nc
viral
rna
encapsid
determin
respons
fiv
nc
bind
rna
yet
report
interestingli
examin
proteolyt
cleavag
nc
reveal
secondari
cleavag
site
within
cterminu
nc
produc
matur
nc
protein
cterminu
kd
protein
although
character
cterminu
kd
protein
yet
describ
amino
acid
sequenc
cleavag
product
contain
psap
motif
similar
ptap
motif
also
character
late
l
domain
encod
gag
protein
motif
within
function
viru
particl
bud
releas
bind
motif
protein
encod
ww
domain
interact
l
domain
cellular
protein
report
critic
bud
investig
potenti
target
antivir
therapeut
examin
signific
potenti
function
ctermin
cleavag
product
fiv
nc
l
domain
fiv
gag
may
warrant
provid
anoth
lentivir
model
character
cellular
protein
import
lentiviru
assembl
releas
addit
ca
nc
protein
encod
fiv
gag
fiv
gag
polyprotein
contain
canc
spacer
region
shown
regul
tempor
gag
process
sever
retrovirus
includ
bovin
immunodefici
viru
biv
rou
sarcoma
viru
rsv
fiv
canc
spacer
region
consist
nine
residu
contain
laeal
motif
also
found
canc
spacer
region
report
indispens
gag
assembl
although
recent
studi
show
fiv
canc
spacer
region
capabl
function
replac
biv
canc
spacer
region
biv
gag
assembl
studi
examin
fiv
canc
spacer
region
fiv
gag
assembl
report
observ
howev
suggest
fiv
gag
may
provid
anoth
model
examin
gag
motif
assembl
fiv
pol
gene
posit
downstream
gag
encod
four
enzym
proteas
pr
revers
transcriptas
rt
dutpas
du
integras
figur
fiv
pol
overlap
gag
gene
nucleotid
read
frame
respect
gag
similar
retrovirus
pol
translat
gagpol
fusion
polyprotein
produc
ribosom
frameshift
facilit
consensu
frameshift
signal
sequenc
gggaaac
within
gagpol
overlap
region
togeth
sequenc
display
potenti
pseudoknot
tertiari
structur
immedi
downstream
signal
sequenc
pol
polypeptid
gagpol
fusion
precursor
protein
cleav
viral
pr
function
enzym
viru
assembl
fiv
pr
kd
protein
facilit
process
gag
gagpol
polyprotein
individu
structur
enzymat
protein
assembl
matur
viru
particl
focu
antivir
therapi
target
pr
promot
interest
fiv
pr
model
design
proteas
inhibitor
well
structur
studi
character
fiv
pr
base
threedimension
crystal
structur
analysi
fiv
pr
homodimer
aspartyl
proteinas
quarternari
structur
similar
pr
despit
conserv
amino
acid
two
enzym
howev
monom
fiv
proteas
compos
amino
acid
compar
amino
acid
pr
regardless
similar
observ
fiv
pr
pr
fiv
pr
exhibit
substrat
specif
restrict
fiv
gag
cleavag
site
exclud
site
within
gag
multipl
residu
substitut
requir
within
fiv
pr
modifi
specif
includ
gag
cleavag
site
furthermor
residu
peripher
activ
site
pr
well
within
activ
site
influenc
bind
substrat
stabil
crucial
residu
within
activ
site
directli
contact
substrat
may
account
differ
substrat
specif
observ
fiv
pr
activ
regardless
dispar
substrat
specif
display
fiv
pr
pr
similar
structur
util
develop
broadbas
inhibitor
bind
hiv
pr
fiv
pr
compar
analys
significantli
increas
understand
molecular
basi
lentiviru
pr
substrat
specif
may
possibl
facilit
develop
pr
inhibitor
less
suscept
resist
develop
revers
transcriptas
encod
retrovirus
rnadepend
dna
polymeras
revers
transcrib
viral
genom
rna
doublestrand
provir
dna
copi
subsequ
integr
host
cellular
genom
dna
fiv
rt
compar
rt
amino
acid
sequenc
structur
physic
properti
catalyt
activ
suscept
multipl
nucleosid
analog
amino
acid
sequenc
analysi
reveal
ident
similar
rt
fiv
rt
like
rt
fiv
rt
exist
heterodim
consist
kd
subunit
kd
subunit
contain
common
nterminu
present
equimolar
concentr
subunit
gener
cleavag
rnase
h
domain
cterminu
rnase
h
domain
fiv
rt
rt
function
revers
transcript
degrad
rna
dnarna
hybrid
importantli
fiv
rt
rt
exhibit
similar
suscept
multipl
nucleosid
analog
howev
fiv
rt
resist
specif
nucleosid
analog
azt
ddi
ddc
map
homolog
residu
within
similarli
drugresist
rt
mutant
contrast
fiv
rt
rt
suscept
nucleosid
analog
map
correspond
codon
ymdd
activ
site
rt
palm
subdomain
studi
also
reveal
uniqu
fiv
mutant
encod
novel
prolin
serin
chang
posit
analog
prolin
residu
resid
within
templat
grip
rt
observ
suggest
mutat
within
region
templat
grip
close
distinct
rt
activ
site
could
influenc
substrat
recognit
conclus
substanti
examin
homolog
rt
mutant
furthermor
function
studi
assess
chimer
rt
molecul
compos
fiv
subunit
demonstr
import
maintain
optim
structur
integr
rt
shed
light
signific
subunit
studi
also
produc
observ
show
lack
fiv
rt
sensit
nonnucleosid
rt
inhibitor
nnrti
found
block
replic
although
amino
acid
line
nnrtispecif
pocket
rt
exhibit
higher
similar
correspond
fiv
rt
residu
rt
catalyt
activ
hivfiv
chimer
rt
also
found
significantli
decreas
compar
wild
type
hiv
fiv
rt
despit
similar
observ
two
molecul
summari
similar
differ
observ
fiv
rt
gener
somewhat
limit
support
use
fiv
rt
model
rttarget
drug
design
studi
drug
resist
cell
cultur
vivo
du
gene
product
express
pol
gene
genom
nonprim
lentivirus
includ
fiv
type
retrovirus
primat
lentivirus
fiv
du
resid
immedi
downstream
rt
pol
polyprotein
packag
activ
form
fiv
virion
du
catalyz
hydrolysi
dutp
dump
inorgan
pyrophosph
ppi
believ
minim
misincorpor
dutp
dna
mutagen
virus
encod
du
enzymat
activ
requir
product
viral
replic
cell
primari
macrophag
express
low
dutpas
activ
infect
cat
du
mutant
fiv
result
fivefold
increas
number
mutat
observ
viral
genom
although
encod
dutpas
activ
recruit
cellular
dna
repair
enzym
uracil
dna
glycosylas
ung
virion
accessori
protein
vpr
also
act
modul
viral
mutat
rate
accordingli
hiv
vpr
activ
impart
similar
effect
fiv
du
viru
replic
differ
mechan
integr
doubl
strand
provir
dna
host
genom
function
retrovir
integras
protein
distinguish
featur
retroviru
replic
addit
direct
role
integr
provir
dna
host
cell
genom
dna
compon
pic
also
contain
newli
synthes
provir
dna
viral
vpr
viral
central
dna
flap
viral
compon
thought
contribut
nuclear
import
pic
may
play
primari
role
similar
fiv
exhibit
karyophil
properti
determin
encod
fiv
nuclear
import
map
ntermin
zincbind
domain
region
rich
basic
residu
near
ctermin
domain
rather
canon
nuclear
local
signal
nl
nl
also
thought
involv
bipartit
signal
instead
includ
residu
peptid
within
central
core
domain
includ
ntermin
zincbind
domain
suggest
mechan
nuclear
import
fiv
integras
molecul
differ
env
gene
fiv
lentivirus
divers
viral
gene
size
sequenc
lentiviru
envelop
protein
play
major
role
viru
life
cycl
encod
determin
interact
cell
surfac
receptor
mediat
fusion
lipid
bilay
viral
envelop
host
cell
plasma
membran
accordingli
variat
viral
envelop
protein
particularli
surfac
glycoprotein
affect
viru
host
cell
tropism
fusogen
well
viru
replic
addit
env
glycoprotein
contain
epitop
elicit
immun
respons
import
diagnosi
protect
immun
fiv
env
express
singli
splice
mrna
revdepend
similar
structur
protein
contrast
primat
lentiviru
env
protein
fiv
env
nonprim
lentivirus
env
protein
encod
lengthi
ntermin
presequ
upstream
hydrophob
region
env
signal
peptid
figur
ntermin
presequ
fiv
env
contain
amino
acid
repres
kd
polypeptid
includ
l
region
env
encod
ntermin
exon
fiv
rev
earli
gene
product
fiv
env
fulllength
uncleav
precursor
kd
glycoprotein
subsequ
process
kd
precursor
cleavag
ntermin
kd
polypeptid
hydrophob
signal
sequenc
precursor
transport
golgi
proteolyt
cleav
produc
matur
fiv
surfac
glycoprotein
su
characterist
hydrophob
membranespan
glycoprotein
tm
su
form
noncoval
associ
tm
anchor
envelop
complex
lipid
bilay
studi
use
glycosyl
inhibitor
confirm
extens
glycosyl
fiv
envelop
protein
similar
observ
hiv
env
demonstr
cell
typespecif
glycosyl
env
studi
also
verifi
role
envelop
protein
glycosyl
viru
infect
signific
structur
function
kd
ntermin
polypeptid
cleavag
product
apart
proper
env
process
well
understood
although
one
studi
reveal
partial
delet
peptid
produc
viru
unabl
infect
primari
felin
astrocyt
still
infecti
felin
lymphocyt
macrophag
structur
model
base
xray
crystallographi
nmr
spectroscopi
indic
envelop
protein
form
trimer
viral
surfac
furthermor
su
bind
primari
receptor
result
conform
chang
facilit
format
ternari
complex
compos
su
coreceptor
molecul
bchemokin
receptor
ternari
complex
trigger
addit
conform
chang
tm
mediat
fusion
envelop
protein
cellular
plasma
membran
model
spatial
fold
fiv
env
su
tm
protein
base
predict
algorithm
use
env
amino
acid
sequenc
multipl
isol
reveal
structur
similar
envelop
protein
includ
conserv
hypervari
domain
fiv
su
tm
princip
immunodomin
domain
pid
within
extracellular
region
tm
conserv
among
lentiviru
transmembran
glycoprotein
includ
tm
also
describ
fiv
tm
figur
despit
conserv
pid
mutat
tm
variabl
region
shown
previous
describ
function
domain
epitop
within
tm
previous
report
includ
fc
fusion
peptid
leucin
zipper
region
princip
immunodomin
domain
pid
epitop
analog
neutral
epitop
tryptophan
w
rich
motif
import
infect
membranespan
region
msr
cytoplasm
domain
cyto
domain
found
alter
fiv
infect
contrast
disrupt
tryptophanrich
domain
also
conserv
among
lentiviru
tm
protein
locat
extracellular
region
immedi
upstream
membranespan
domain
abrog
viru
entri
find
second
studi
demonstr
role
fiv
tm
tryptophanrich
domain
envmedi
fusion
viral
cellular
membran
thu
provid
probabl
mechan
domain
affect
viru
infect
final
synthet
peptid
model
tryptophanrich
domain
found
inhibit
fiv
replic
find
parallel
data
demonstr
import
similar
tryptophanrich
domain
encod
hiv
tm
entri
fusiogen
effect
suggest
fiv
tm
may
share
one
mechan
necessari
fusion
viral
cellular
membran
howev
detail
structur
analysi
fiv
envelop
protein
interact
cell
surfac
receptor
base
xray
crystallographi
need
thorough
comparison
fiv
envelop
protein
state
earlier
chapter
envelop
protein
exhibit
greatest
divers
amino
acid
among
protein
encod
lentivirus
comparison
differ
hiv
isol
five
interspers
conserv
five
variabl
domain
identifi
env
gene
similarli
analysi
amino
acid
sequenc
deriv
env
gene
differ
isol
fiv
result
identif
nine
variabl
region
separ
region
conserv
figur
furthermor
examin
domain
within
sucod
sequenc
reveal
genet
divers
differ
isol
allow
separ
fiv
isol
five
clade
subtyp
design
e
possibl
sixth
subtyp
aris
subtyp
b
cluster
found
texa
divers
subtyp
vari
wherea
variat
within
subtyp
rang
find
similar
isol
although
geograph
separ
like
major
factor
emerg
genet
divers
fiv
individu
subtyp
identifi
geograph
isol
region
world
tabl
fiv
subtyp
b
isol
detect
unit
state
europ
japan
australia
wherea
subtyp
c
variant
found
north
america
europ
taiwan
subtyp
isol
also
detect
central
south
america
three
fiv
subtyp
b
c
isol
singl
locat
munich
germani
subtyp
e
isol
character
far
restrict
japan
argentina
respect
multipl
genet
analys
indic
vast
major
fiv
isol
either
subtyp
b
interestingli
find
one
report
reveal
twice
mani
synonym
site
chang
within
fiv
subtyp
b
envelop
domain
compar
detect
subtyp
envelop
although
subtyp
b
envelop
encod
similar
number
nonsynonym
site
chang
greater
divers
observ
subtyp
b
suggest
fiv
subtyp
may
repres
older
viru
signific
divers
fiv
subtyp
b
variant
also
shown
virus
isol
cat
itali
subtyp
highli
preval
find
studi
gener
phylogenet
analysi
focus
sequenc
gag
fragment
isol
su
sequenc
four
isol
final
higher
divers
subtyp
support
two
recent
studi
examin
gag
envelop
sequenc
deriv
fiv
subtyp
b
isol
austria
subtyp
b
predomin
reveal
subtyp
b
cluster
suffici
genet
divers
support
design
subclad
second
studi
character
cluster
fiv
isol
texa
close
relat
fiv
subtyp
b
virus
subtyp
yet
clearli
distinct
subtyp
find
studi
suggest
viru
cluster
either
separ
subtyp
recent
emerg
subtyp
b
repres
subgroup
within
subtyp
b
collect
find
strengthen
hypothesi
fiv
subtyp
b
older
viru
exist
within
domest
cat
popul
longer
time
period
fiv
subtyp
host
adapt
lower
virul
suggest
associ
fiv
b
subtyp
isol
confirm
rigor
examin
sever
report
also
present
evid
natur
occur
experiment
induc
intersubtyp
recombin
virus
deriv
recombin
within
env
gene
observ
intersubtyp
recombin
involv
common
breakpoint
within
gag
also
recent
report
find
fiv
agre
report
recombin
isol
gener
diverg
hiv
subtyp
geograph
region
multipl
hiv
subtyp
found
identif
multipl
subtyp
signific
diverg
within
major
subtyp
b
virus
confirm
natur
occur
fiv
recombin
relev
issu
fiv
vaccin
design
suggest
vaccin
specif
geograph
area
subtyp
preval
may
requir
similar
issu
exist
vaccin
design
provid
opportun
fiv
one
regulatori
gene
rev
two
accessori
gene
vif
orfa
character
fiv
genom
although
sever
research
group
shown
fiv
rev
fiv
vif
provid
function
viru
replic
similar
describ
analog
protein
exhaust
examin
fiv
gene
product
report
fiv
accessori
gene
clearli
analog
primat
lentiviru
regulatori
accessori
gene
includ
tat
vpr
vpu
vpx
nef
identifi
earli
report
propos
fiv
orfa
encod
tat
gene
product
howev
studi
test
orfa
transactiv
fiv
ltr
demonstr
orfa
activ
compar
tat
recent
find
suggest
fiv
orfa
may
express
function
similar
vpr
perhap
vpu
although
data
support
premis
limit
howev
possibl
viral
function
activ
express
multipl
uniqu
accessori
protein
may
encompass
singl
fiv
accessori
protein
along
specif
domain
within
fiv
structur
protein
warrant
examin
genom
member
lentiviru
subfamili
encod
revlik
posttranscript
regulatori
protein
express
earli
viral
life
cycl
multipli
splice
mrna
speci
contain
either
orfa
l
region
env
orfh
l
region
env
orfh
fiv
rev
kd
protein
express
two
exon
deriv
l
region
env
orfh
figur
first
rev
exon
extend
termin
l
region
env
gene
open
read
frame
env
second
exon
orfh
locat
terminu
env
gene
overlap
terminu
ltr
similar
rev
fiv
rev
nucleolar
protein
bind
multim
cisact
regulatori
rre
sequenc
contain
within
unsplic
singli
splice
viral
mrna
promot
nuclear
export
mrna
speci
cytoplasm
also
increas
mrna
stabil
protein
translat
fiv
rev
contain
highli
basic
domain
similar
describ
lentiviru
rev
protein
basic
domain
locat
second
exon
like
serv
rre
bind
domain
although
studi
confirm
function
fiv
rev
element
report
anoth
viral
mrna
contain
second
rev
exon
orfh
also
identifi
encod
truncat
rev
protein
design
rev
rev
contain
highli
basic
domain
effector
domain
rev
lack
n
terminu
deriv
first
exon
truncat
rev
protein
exhibit
rev
activ
vitro
assay
activ
observ
wild
type
fulllength
fiv
rev
signific
rev
viru
replic
character
express
fiv
structur
enzymat
protein
includ
vif
depend
rev
express
activ
accordingli
rev
regulatori
system
essenti
product
viru
replic
although
fiv
rev
share
similar
activ
function
rev
fiv
rev
effector
activ
domain
locat
immedi
downstream
basic
domain
contain
nuclear
export
signal
ne
differ
significantli
amino
acid
sequenc
describ
rev
effector
domain
primat
ungul
lentivirus
fiv
rev
effector
domainn
lack
organ
hydrophob
residu
leucinerich
cluster
core
tetram
properti
defin
rev
ne
instead
fiv
rev
effector
domainn
character
basic
residu
dispers
leucin
residu
similar
observ
equin
infecti
anemia
viru
eiav
rev
howev
fiv
eiav
rev
effector
domain
function
replac
effector
domain
rev
find
suggest
fiv
rev
protein
util
similar
cellular
pathway
activ
similar
fiv
rev
rev
support
studi
demonstr
nuclear
export
fiv
eiav
rev
protein
well
rev
function
inhibit
leptomycin
b
drug
previous
shown
block
rev
ne
interact
exportin
observ
suggest
bind
nuclear
export
may
properti
fiv
rev
share
rev
regardless
dissimilar
activ
domain
anoth
function
properti
share
fiv
rev
regulatori
system
involv
interact
cellular
eukaryot
initi
factor
also
associ
rev
nuclear
export
unsplic
singli
splice
viral
mrna
biolog
activ
previous
shown
requir
rev
function
specif
facilit
bind
revrr
complex
activ
requir
synthesi
uniqu
amino
acid
hypusin
sustain
deoxyhypusin
synthetas
recent
report
reveal
inhibitor
deoxyhypusin
synthetas
significantli
inhibit
fiv
replic
specif
restrict
fiv
rev
function
taken
togeth
observ
demonstr
similar
share
fiv
rev
protein
valid
fiv
rev
model
potenti
antivir
therapi
target
rev
accessori
gene
design
vif
conserv
among
lentivirus
except
eiav
determin
encod
factor
necessari
virion
cellfre
infect
although
requir
virion
product
fiv
vif
resid
terminu
pol
gene
viral
genom
translat
singli
splice
mrna
express
basic
protein
figur
role
fiv
vif
viral
infect
primari
felin
lymphocyt
macrophag
clearli
establish
howev
biochem
character
fiv
vif
limit
restrict
one
report
describ
nuclear
local
fiv
accessori
protein
studi
regard
mechan
vif
function
far
focus
instead
primat
lentiviru
vif
protein
earli
studi
demonstr
replic
phenotyp
vifdelet
hiv
mutant
cell
typedepend
specif
depend
cell
produc
virion
cell
type
includ
primari
lymphocyt
macrophag
well
specif
tcell
line
requir
presenc
vif
express
product
infecti
hiv
design
nonpermiss
replic
vifdelet
mutant
howev
specif
human
tcell
line
design
permiss
cell
includ
cell
jurkat
cell
support
product
viru
replic
vifdelet
variant
cell
fusion
experi
show
heterokaryon
form
permiss
nonpermiss
cell
display
nonpermiss
phenotyp
suggest
nonpermiss
cell
natur
express
antivir
activ
inhibit
replic
vifdefici
viru
virion
produc
nonpermiss
cell
absenc
vif
gene
impair
revers
transcript
genom
rna
therefor
fail
establish
fulllength
provirus
entri
target
cell
small
number
report
focus
fiv
vif
date
reveal
felin
cell
line
permiss
vif
delet
mutant
fiv
observ
may
due
part
establish
felin
tcell
line
avail
permiss
primari
wild
type
isol
fiv
recent
report
reveal
major
breakthrough
understand
vif
function
interact
host
cell
protein
sheehi
colleagu
first
identifi
cellular
protein
design
nonpermiss
cell
factor
respons
product
noninfecti
viru
particl
absenc
vif
later
identifi
cell
protein
close
relat
member
cytidin
deaminas
famili
nucleic
acidedit
enzym
numer
studi
establish
cellular
factor
exert
antivir
effect
deamin
cytosin
uracil
singlestrand
minusstrand
dna
revers
transcript
result
either
degrad
newli
synthes
minusstrand
dna
guanidin
adenin
hypermut
final
doublestrand
provir
dna
product
absenc
vif
packag
virion
allow
cellular
protein
exert
antivir
effect
revers
transcript
virion
entri
target
cell
howev
present
virion
assembl
vif
form
complex
human
target
cellular
factor
proteosom
degrad
therebi
prevent
virion
encapsid
facilit
particl
infect
advanc
elucid
vif
function
gener
new
enthusiasm
design
antivir
therapeut
target
vif
interact
recent
studi
also
confirm
primat
lentiviru
siv
vif
protein
also
target
simian
cell
although
interact
appear
speciesspecif
simian
speci
whether
nonprim
lentiviru
vif
protein
includ
fiv
vif
function
similarli
interact
speciesspecif
analog
yet
determin
evid
support
possibl
deriv
report
demonstr
degrad
mediat
vif
slq
yf
la
domain
amino
acid
motif
conserv
among
lentiviru
vif
protein
includ
fiv
vif
fiv
gene
orfa
also
refer
encod
amino
acid
accessori
protein
previous
implic
encod
tatlik
protein
critic
effici
viral
replic
peripher
blood
mononuclear
cell
pbmc
vitro
vivo
although
orfa
gene
product
contain
cysteinerich
domain
within
terminu
similar
tat
protein
encod
ungul
lentivirus
gene
product
includ
core
basic
domain
compar
found
tat
protein
encod
primat
lentivirus
eiav
biv
amino
acid
sequenc
align
fiv
orfa
visna
viru
caev
tat
protein
reveal
similar
organ
conserv
put
domain
includ
ntermin
hydrophob
central
leucinerich
ctermin
cysteinerich
region
addit
fiv
orfa
encod
previous
unrecogn
conserv
tryptophan
posit
posit
similarli
conserv
tryptophan
residu
visna
viru
tat
two
recent
studi
demonstr
moder
upregul
fiv
ltr
promot
activ
coexpress
orfa
transient
report
gene
express
assay
contrast
earlier
report
reveal
either
small
effect
effect
impos
orfa
fiv
ltrdirect
gene
express
find
suggest
orfa
like
drive
fivltrdirect
transcript
indirect
mechan
involv
interact
cellular
transcript
factor
recent
report
reveal
orfa
import
late
step
fiv
life
cycl
involv
virion
format
earli
step
involv
viru
infect
map
critic
orfa
domain
need
step
replic
central
leucinerich
ctermin
cysteinerich
region
along
conserv
central
tryptophan
residu
within
orfa
shown
critic
determin
effici
viru
replic
infect
leucinerich
domain
import
infect
wherea
tryptophan
cysteinerich
domain
import
infect
virion
format
importantli
delet
point
mutat
orfa
impos
small
effect
fiv
ltrdriven
viral
gene
express
effect
viral
protein
express
find
suggest
orfa
repres
fivencod
analog
similar
accessori
gene
vpr
vpu
nef
rather
regulatori
tat
gene
encod
primat
lentivirus
concept
support
anoth
recent
studi
use
mammalian
express
plasmid
encod
wild
type
delet
mutant
orfa
protein
fuse
green
fluoresc
protein
gfp
evalu
orfa
subcellular
local
effect
cell
function
find
studi
demonstr
nuclear
local
gfporfa
fusion
protein
allow
map
nl
residu
critic
nuclear
import
fiv
orfa
furthermor
assess
cell
cycl
profil
cell
transient
express
gfporfa
reveal
orfa
caus
arrest
cell
cycl
novel
find
suggest
orfa
nuclear
protein
express
properti
similar
report
vpr
collect
data
gener
report
suggest
possibl
orfa
may
encod
specif
function
attribut
sever
differ
encod
accessori
protein
function
character
singl
accessori
protein
addit
support
possibl
provid
recent
report
show
caev
tat
share
structur
homolog
fiv
orfa
also
local
nucleu
arrest
cell
verif
find
fiv
orfa
research
group
orfa
protein
encod
multipl
fiv
isol
need
confirm
similar
fiv
orfa
vpr
accessori
protein
natur
experiment
infect
cat
biolog
molecularli
clone
isol
fiv
consist
induc
acut
viremia
associ
tcell
alter
includ
depress
tcell
ratio
tcell
deplet
earli
studi
reveal
target
fiv
vitro
vivo
includ
tcell
macrophag
dendrit
cell
microglia
astrocyt
similar
hiv
infect
human
also
includ
tcell
bcell
tabl
ii
earli
report
also
demonstr
continu
passag
particular
fiv
isol
cell
cultur
select
viru
variant
capabl
replic
felin
adher
cell
line
includ
crandel
felin
kidney
cell
crfk
cell
well
establish
felin
interleukin
il
tcell
line
importantli
experiment
inocul
studi
cat
reveal
cell
cultureadapt
virus
repres
particular
subset
viral
variant
exhibit
reduc
replic
virul
vivo
fiv
infect
felin
adher
cell
line
provid
indirect
evid
fiv
differ
util
primari
receptor
addit
direct
evid
refut
fiv
usag
provid
studi
reveal
absenc
viru
infect
nonlymphoid
cell
express
felin
subsequ
report
describ
block
fiv
infect
antibodi
specif
felin
cell
surfac
antigen
belong
fourtransmembranespan
domain
superfamili
howev
antibodi
later
shown
block
viru
infect
inhibit
viru
releas
interfer
virusreceptor
bind
major
breakthrough
character
fiv
cell
surfac
receptor
result
observ
show
cell
cultureadapt
fiv
isol
primarili
util
bchemokin
receptor
infect
similar
fashion
tcell
lineadapt
isol
tabl
ii
induc
cell
surfac
express
shown
mediat
suscept
fiv
infect
could
abrog
treatment
natur
ligand
stromal
cellderiv
factor
antagonist
includ
furthermor
critic
determin
fiv
infect
map
extracellular
loop
multipl
report
confirm
cell
cultureadapt
fiv
isol
capabl
use
exclus
viru
entri
infect
result
subsequ
report
suggest
fiv
usag
chemokin
receptor
conflict
observ
investig
may
result
enhanc
express
associ
ectop
express
use
chemokin
receptor
particular
fiv
isol
clear
time
investig
similar
envelop
protein
bind
fiv
env
cell
surfac
maker
includ
heparan
sulfat
proteoglycan
hspg
dcsign
shown
specif
particular
isol
bind
dcsign
observ
recombin
env
protein
deriv
primari
cell
culturepassag
fiv
isol
wherea
bind
hspg
observ
cell
culturepassag
fiv
strain
although
viru
entri
shown
mediat
exclus
viru
infect
enhanc
factor
includ
temperatur
hspg
either
increas
concentr
bind
respect
role
bind
dcsign
hspg
fiv
env
fiv
infect
pathogenesi
vivo
current
well
understood
warrant
examin
previou
studi
confirm
receptor
also
reveal
express
suffici
infect
primari
fiv
isol
suggest
likehood
primari
isol
requir
second
receptor
bind
entri
one
report
describ
coimmunoprecipit
recombin
fiv
envelop
protein
kd
cellular
protein
provid
evid
receptor
fiv
second
major
advanc
fiv
receptor
biolog
recent
identif
cellular
protein
kd
cell
surfac
marker
receptor
util
primari
fiv
isol
conjunct
member
tumor
necrosi
factorreceptor
superfamili
express
primarili
activ
tcell
mous
human
tcell
receptor
tcr
engag
recent
report
confirm
similar
phenotyp
felin
show
upregul
express
mitogenactiv
felin
tcell
bind
cell
surfac
cellular
ligand
provid
costimulatori
signal
result
proinflammatori
effect
well
prolifer
migrat
cytokin
product
memori
tcell
low
level
express
also
report
activ
tcell
activ
bcell
macrophag
mice
human
confirm
felin
cell
lineag
far
preliminari
report
indic
infect
primari
isol
requir
bind
assess
receptor
usag
larger
panel
primari
fiv
isol
need
determin
addit
chemokin
receptor
may
also
use
fiv
infect
previous
observ
may
associ
specif
fiv
replicationpathogen
phenotyp
whether
infect
tcell
bcell
macrophag
previous
observ
later
stage
fiv
infect
due
usag
express
cell
popul
result
usag
yet
clarifi
clearli
usag
receptor
primari
fiv
isol
explain
specif
target
tcell
popul
deplet
observ
fiv
infect
similar
acquir
immunodefici
induc
fiv
furthermor
observ
elucid
mechan
fiv
util
uniqu
receptor
target
similar
subset
tcell
ie
activ
rest
memori
tcell
impart
diseas
pathogenesi
accordingli
find
valid
import
fiv
infect
model
examin
aid
examin
pathogen
effect
cellular
dysfunct
impos
virusbind
express
tcell
vitro
also
import
defin
potenti
viral
mechan
induct
felin
acquir
immunodefici
vivo
replic
phenotyp
vitro
vivo
clearli
distinguish
cell
cultureadapt
fiv
isol
primari
isol
primari
fiv
isol
examin
date
requir
infect
exhibit
cell
tropism
restrict
primari
felin
pbmc
select
tcell
line
possibl
primari
macrophag
astrocyt
although
test
tropism
latter
two
cell
type
infrequ
report
tabl
ii
contrast
fiv
variant
passag
vitro
util
sole
effici
infect
replic
felin
adher
cell
line
includ
crfk
cell
well
felin
pbmc
independ
felin
tcell
line
macrophag
highli
passag
isol
howev
exhibit
sever
restrict
viru
replic
pathogen
vivo
discuss
multipl
studi
use
fiv
molecular
clone
map
env
major
determin
expand
cell
tropism
includ
felin
adher
cell
line
includ
crfk
cell
cell
felin
glial
cell
line
well
felin
astrocyt
tabl
ii
similar
domain
env
domain
fiv
su
encod
specif
tropism
determin
addit
import
neutral
antibodi
epitop
figur
critic
amino
acid
residu
map
within
fiv
env
domain
appear
determin
adher
cell
tropism
modifi
overal
charg
loop
recent
report
describ
evolut
nonpathogen
fiv
isol
pathogen
viru
vivo
time
suggest
mutat
within
loop
impos
crfk
cell
tropism
also
contribut
viru
attenu
hypothesi
support
consist
observ
sever
restrict
replic
vivo
observ
virus
exhibit
tropism
crfk
cell
vitro
env
determin
affect
fiv
cell
tropism
adher
cell
map
second
constant
domain
within
su
extracellular
domain
tm
cytoplasm
domain
tm
although
domain
fiv
su
also
report
influenc
fiv
macrophag
brain
microglia
tropism
viral
determin
critic
macrophag
tropism
well
frequenc
macrophag
tropism
across
mani
primari
isol
well
examin
fiv
mechan
import
env
residu
domain
contribut
viru
infect
cell
type
either
effect
env
conform
bind
affin
either
also
well
understood
time
warrant
investig
character
fiv
anim
model
multipl
report
confirm
gene
product
accessori
gene
orfa
critic
determin
infect
felin
pbmc
requir
infect
adher
cell
line
includ
crfk
cell
howev
role
orfa
fiv
tropism
felin
macrophag
receiv
limit
studi
unclear
base
conflict
data
report
differ
studi
mechan
orfa
impact
viru
infect
pbmc
also
undetermin
time
interestingli
earli
studi
suggest
restrict
product
fiv
infect
human
cell
result
primarili
block
fiv
transcript
rather
block
viru
entri
capabl
fiv
isol
establish
latent
infect
human
cell
later
explain
demonstr
cell
cultur
adaptedfiv
usag
human
fusion
infect
human
cell
subsequ
studi
focus
fiv
vector
develop
reveal
fiv
domain
determin
respons
restrict
viru
replic
human
cell
show
replac
cytomegaloviru
immedi
earli
promot
produc
fiv
vector
capabl
viral
gene
express
human
cell
studi
report
one
research
group
show
fiv
capabl
product
infect
primat
cell
vitro
vivo
confirm
independ
research
suggest
fiv
infect
nonfelin
cell
may
warrant
examin
similar
lentivirus
presenc
fivspecif
antibodi
signifi
establish
viru
infect
persist
throughout
remain
lifetim
host
antibodi
detect
elisa
immunochromatograph
method
exclud
western
blot
serv
primari
screen
diagnost
assay
fiv
infect
clinic
veterinari
practic
epidemiolog
studi
although
fivinfect
cat
produc
antibodi
gag
env
structur
protein
small
proport
cat
test
posit
antibodi
specif
one
two
structur
protein
therefor
current
avail
commerci
fiv
antibodi
assay
includ
fiv
gag
env
recombin
antigen
optim
sensit
well
specif
current
earlier
serolog
studi
shown
fiv
enzoot
worldwid
evalu
mutat
within
viru
subtyp
suggest
fiv
present
domest
cat
signific
period
time
especi
compar
rel
short
evolut
hiv
fiv
preval
vari
greatli
depend
geograph
locat
variabl
test
cat
popul
among
clinic
healthi
cat
preval
fiv
may
low
less
observ
central
european
countri
unit
state
high
report
japan
australia
seropreval
rate
sick
cat
appear
sever
time
higher
healthi
counterpart
reflect
diseaseinduc
potenti
fiv
age
gender
also
markedli
affect
fiv
preval
infect
acquir
one
year
age
preval
increas
approxim
year
age
remain
stabl
tend
declin
mean
lifespan
domest
cat
year
virus
similar
fiv
document
sever
nondomest
felid
lion
panther
bobcat
larg
genet
divers
observ
lentivirus
among
differ
nondomest
felid
nondomest
felin
lentivirus
fiv
howev
support
likelihood
nondomest
felin
lentivirus
contribut
significantli
circul
fiv
domest
cat
littl
evid
fiv
transmiss
speci
includ
human
except
recent
singl
report
describ
experiment
fiv
infect
nonhuman
primat
cynomolgu
macaqu
precis
mode
natur
fiv
transmiss
among
domest
cat
yet
clear
nevertheless
strong
epidemiolog
evid
impli
bite
fight
may
predomin
rout
transmiss
tabl
iii
import
rout
transmiss
corrobor
observ
highest
preval
infect
rural
feral
cat
popul
urban
area
contain
high
densiti
freeli
roam
cat
japan
higher
preval
infect
adult
tomcat
fact
one
epidemiolog
studi
reveal
pattern
increas
fiv
infect
orang
cat
compar
nonorang
cat
correl
pattern
aggress
behavior
also
exhibit
orang
cat
addit
evid
viru
saliva
harvest
infect
cat
infect
experi
involv
viru
inocul
simul
bite
substanti
transmiss
rout
highli
effect
earli
epidemiolog
experiment
infect
studi
refut
possibl
natur
occur
vertic
transmiss
fiv
howev
later
experiment
inocul
studi
confirm
viru
transmiss
newborn
kitten
queen
either
acut
chronic
infect
differ
fiv
isol
transmiss
appear
occur
via
utero
postnat
rout
although
intrapartum
transmiss
also
implic
interestingli
recent
studi
provid
evid
vertic
transmiss
result
occult
infect
kitten
character
presenc
viral
dna
tissu
absenc
replic
viru
peripher
blood
well
absenc
antivir
antibodi
apart
matern
antibodi
although
occult
infect
result
vertic
transmiss
consid
regress
transient
report
one
studi
durat
persist
type
infect
thoroughli
examin
covert
occult
infect
resembl
previous
describ
restrict
fiv
infect
detect
pcr
amplif
viral
dna
blood
tissu
result
either
inocul
extrem
attenu
virus
persist
nontraumat
contact
naiv
infect
cat
furthermor
similar
sequest
viru
infect
absenc
antibodi
report
siv
infect
implic
particular
human
popul
high
risk
hiv
infect
collect
find
suggest
possibl
incid
natur
fiv
infect
vertic
transmiss
may
underestim
sinc
diagnost
assay
focu
antibodi
viru
peripher
blood
detect
viru
semen
infect
cat
observ
experiment
infect
artifici
insemin
also
report
numer
experiment
studi
shown
feasibl
infect
vagin
rout
demonstr
util
lymphoid
follicular
hyperplasia
fiv
earli
tcell
subset
expans
follow
lymphoid
deplet
tcell
deplet
cytokin
dysregul
aid
felin
anim
model
examin
mucos
transmiss
viral
pathogenesi
although
observ
experiment
studi
suggest
possibl
sexual
transmiss
fiv
definit
observ
natur
transmiss
rout
far
report
primari
felin
pbmc
activ
concanavalin
cona
specif
felin
tcell
line
includ
cell
cell
cell
cell
cell
proven
highli
permiss
propag
biolog
specif
molecularli
clone
isol
fiv
describ
section
discuss
fiv
receptor
usag
product
viru
replic
cell
type
result
express
felin
cell
surfac
molecul
confirm
least
activ
felin
pbmc
cell
tabl
ii
establish
felin
adher
cell
line
includ
crfk
cell
cell
well
felin
lymphoid
cell
line
cell
use
propag
isol
felin
lymphoid
cell
line
cell
chronic
infect
fiv
isol
fivpetaluma
also
gener
product
viru
use
whole
kill
viru
vaccin
diagnost
assay
use
confirm
viru
replic
product
vitro
includ
fiv
antigen
captur
elisa
rt
assay
indirect
immunofluoresc
immunocytochem
assay
viral
structur
protein
pcr
assay
viral
nucleic
acid
quantit
realtim
pcr
assay
fiv
rna
dna
develop
quantit
viral
nucleic
acid
differ
isol
either
cell
cultur
supernat
plasma
cell
appear
virusinduc
cytopath
effect
cpe
consist
syncytium
giant
cell
format
cell
lysi
tabl
ii
felin
pbmc
tcell
line
may
pbmc
donor
fiv
isolatedepend
proven
less
depend
use
marker
viru
infect
cell
type
contrast
infect
adher
cell
line
crfk
lymphoid
cell
line
fiv
isol
may
result
prolif
cpe
consist
observ
crfk
cell
may
serv
indic
infect
isol
fiv
strain
select
extens
cell
cultur
passag
biolog
isol
mimic
isol
also
extrem
cytopath
effici
replic
establish
tcell
line
vitro
knowledg
regard
acut
fiv
infect
viru
local
dissemin
deriv
experiment
inocul
studi
use
biolog
molecularli
clone
fiv
isol
factor
may
affect
viru
local
distribut
acut
phase
infect
viru
pathogen
viru
tropism
titer
viru
inocula
presenc
virusinfect
cell
inocula
rout
use
viru
infect
age
host
experiment
studi
test
highli
pathogen
attenu
fiv
isol
virus
inocul
parenter
mucos
rout
cellfre
cellassoci
viru
inocula
report
howev
care
examin
effect
impos
variabl
viral
distribut
ultim
diseas
well
mechan
effect
yet
describ
regardless
report
far
describ
viru
distribut
pattern
pathogen
fiv
isol
vivo
similar
report
tabl
iii
earli
publish
experiment
infect
studi
design
examin
fiv
local
vivo
use
either
intraperiton
intraven
intramuscular
intrathec
bone
marrow
inocul
specif
pathogenfre
cat
variou
fiv
isol
blood
tissu
harvest
infect
cat
assay
infect
viru
isol
pbmc
viral
nucleic
acid
detect
pcr
situ
hybrid
viral
antigen
detect
immunocytochem
analys
later
report
describ
experiment
studi
test
viru
local
viru
mucos
deliveri
either
vagin
rectal
oralnas
rout
addit
either
intraperiton
intraven
rout
intracrani
inject
viru
local
system
lymphoid
central
nervou
system
cn
tissu
fiv
provir
dna
inocul
also
examin
collect
studi
reveal
local
viru
pbmc
plasma
peripher
system
lymphoid
tissu
small
larg
intestin
tract
cn
tissu
within
day
inocul
host
regardless
rout
infect
test
fact
one
report
describ
viru
detect
gastrointestin
mucosa
associ
lymphoid
tissu
day
oralnas
infect
rapid
dissemin
viru
system
lymphoid
tissu
bone
marrow
pbmc
within
day
infect
similarli
viru
detect
vagin
mucosa
spleen
within
day
vagin
deliveri
viru
howev
viru
infect
vagin
mucosa
examin
studi
observ
test
vagin
deliveri
specif
viru
isol
fivppr
observ
vagin
infect
fiv
isol
intraven
viru
infect
similar
observ
siv
anim
model
experiment
fiv
infect
mucos
rout
gener
requir
higher
titer
viru
inocula
requir
parenter
inject
one
studi
report
higher
effici
infect
cellfre
viru
inocula
compar
cellassoci
viru
viru
also
detect
nonlymphoid
organ
includ
liver
kidney
importantli
fiv
infect
cn
well
document
util
anim
model
neurolog
deficit
kinet
viru
emerg
blood
individu
tissu
vari
depend
rout
inocul
viru
strain
infecti
titer
viru
inocula
viru
load
peripher
blood
base
either
viru
isol
pbmc
plasma
viral
rna
quantit
may
peak
anywher
day
experiment
infect
signific
viru
load
acut
stage
infect
may
also
observ
peripher
system
lymph
node
gastrointestin
tissu
predominantli
submucosa
lamina
propria
spleen
thymu
bone
marrow
preced
appear
peak
viremia
peripher
blood
find
gener
mimic
viru
distribut
acut
infect
pathogen
siv
isol
tabl
iii
discuss
previou
section
chapter
fiv
differ
exhibit
broader
tropism
vivo
also
includ
megakaryocyt
tcell
bcell
although
report
describ
either
siv
infect
tcell
variat
observ
differ
report
regard
frequenc
stage
infect
viru
viral
nucleic
acid
detect
macrophag
tcell
bcell
may
relat
differ
viru
isol
rout
use
viru
infect
age
host
viru
detect
assay
howev
sever
studi
report
either
tcell
specif
tcell
blood
tissu
predomin
cell
type
harbor
viru
acut
stage
infect
viru
load
tcell
popul
decreas
time
host
progress
chronic
infect
viru
load
macrophag
bcell
appear
increas
relationship
stage
infect
viru
load
specif
cell
popul
includ
tcell
mucos
dendrit
cell
lymph
node
follicular
dendrit
cell
thymocyt
cell
within
cn
nonlymphoid
tissu
receiv
littl
examin
far
although
one
report
reveal
decreas
fivinfect
tcell
lymphoid
tissu
week
infect
recent
report
describ
fiv
infect
vivo
tcell
cell
popul
reminisc
immunosuppress
regulatori
treg
cell
treg
cell
popul
isol
fivinfect
cat
shown
anoth
recent
report
coexpress
costimulatori
molecul
anerg
resist
clonal
delet
find
warrant
investig
suggest
treg
cell
may
serv
import
longliv
reservoir
latent
fiv
lymphoid
tissu
current
examin
potenti
reservoir
infect
vivo
fiv
infect
result
progress
impair
immun
system
includ
loss
tcell
invert
ratio
heighten
suscept
infecti
agent
disrupt
immun
cell
function
deterior
major
lymphoid
tissu
organ
host
observ
studi
involv
either
experiment
natur
infect
show
fiv
diseas
cours
similar
induc
infect
similarli
divid
four
five
stage
base
type
sever
clinic
sign
infect
stage
infect
describ
acut
primari
chronic
asymptomat
persist
gener
lymphadenpathi
pgl
aidsrel
complex
arc
felin
aid
faid
notabl
fiv
infect
usual
associ
prolong
asymptomat
phase
last
year
infect
human
cat
constitut
lifetim
infect
cat
contrast
pathogen
siv
isol
induc
acceler
progress
immunodefici
result
death
within
year
infect
rhesu
macaqu
rel
short
absent
asymptomat
phase
infect
acut
phase
begin
week
fiv
infect
may
span
time
period
month
stage
infect
character
transient
peak
peripher
blood
plasma
pbmc
viru
load
accompani
precipit
declin
tcell
count
tcell
ratio
depend
pathogen
viru
isol
age
host
clinic
hematolog
abnorm
may
includ
gener
lymphadenopathi
mild
pyrexia
dull
depress
anorexia
neutropenia
similar
find
infect
fiv
pathogen
clinic
prognosi
correl
viru
replic
load
sever
clinic
sign
hematolog
deficit
exhibit
acut
phase
infect
anoth
properti
share
fiv
acut
infect
relat
effect
age
host
sever
clinic
hematolog
diseas
time
infect
multipl
studi
shown
sever
primari
phase
fivinduc
diseas
increas
neonat
kitten
experiment
infect
birth
primari
fiv
infect
reced
host
gener
virusspecif
immun
respons
viru
load
decreas
concord
emerg
antivir
immun
respons
reduc
peripher
blood
viru
load
increas
tcell
count
tcell
ratio
although
peripher
blood
tcell
count
usual
return
preinfect
concentr
infect
cat
enter
rel
asymptomat
phase
fiv
infect
control
viru
load
host
immun
respons
presum
may
last
year
signific
proport
remain
life
span
cat
howev
longterm
observ
experiment
natur
infect
cat
shown
peripher
blood
tcell
count
slowli
progress
decreas
asymptomat
phase
clinic
diseas
eventu
becom
appar
care
observ
infect
cat
time
may
reveal
reappear
pgl
earli
manifest
clinic
diseas
associ
vagu
sign
diseas
includ
recurr
fever
weight
loss
appear
pgl
vagu
clinic
sign
infect
cat
gener
progress
arc
phase
character
develop
chronic
persist
infect
pathogen
usual
selflimit
involv
oral
caviti
upper
respiratori
tract
ocular
tissu
skin
bodi
site
progress
arc
faid
may
distinguish
infect
opportunist
pathogen
sever
wast
neoplast
disord
includ
nontcel
lymphoma
neurolog
diseas
leukopenia
anemia
viru
load
increas
sever
deplet
peripher
blood
tcell
observ
surviv
time
usual
less
year
onset
faid
gradual
progress
tcell
deplet
mimic
primari
immun
defici
observ
aid
hallmark
immunodefici
associ
experiment
natur
fiv
infect
cat
tcell
subset
deplet
observ
peripher
blood
lymphoid
tissu
includ
thymu
earli
chronic
stage
infect
tabl
iii
increas
tcell
concentr
frequent
associ
reduct
tcell
count
either
contribut
larg
account
lower
tcell
ratio
observ
acut
chronic
infect
either
fiv
elev
tcell
count
due
increas
b
low
subset
concurr
reduct
b
high
tcell
involv
lymphocyt
popul
peripher
blood
lymph
node
thymu
similar
expans
b
low
tcell
subset
also
observ
infect
furthermor
cell
popul
shown
express
marker
associ
lymphocyt
activ
adhes
exhibit
antivir
activ
compar
noncytolyt
antivir
activ
previous
describ
infect
fivinduc
immunodefici
character
defect
similar
describ
infect
includ
reduc
prolif
tcell
respons
mitogen
dysregul
cytokin
network
humor
immun
respons
deficit
sever
studi
reveal
significantli
reduc
mitogeninduc
blastogen
respons
tcell
isol
cat
acut
chronic
fiv
infect
find
may
result
virusassoci
defect
tcell
growth
prolifer
well
defect
cell
surfac
express
receptor
requir
transmiss
antigenmitogen
signal
although
cytokin
respons
differ
lymphoid
tissu
harvest
cat
acut
infect
fiv
shown
heterogen
find
number
report
suggest
dysregul
cytokin
tumor
necrosi
factor
tnf
alpha
interferon
gamma
may
play
role
fivinduc
immun
defici
deficit
gener
antibodi
respons
multipl
antigen
specif
tcelldepend
immunogen
also
report
fivinfect
cat
bone
marrow
abnorm
may
result
neutropenia
leukopenia
pancytopenia
well
deficit
neutrophil
monocytemacrophag
function
may
impair
immunolog
function
fivinfect
cat
histolog
lesion
associ
fiv
infect
predominantli
local
lymphoid
tissu
includ
galt
earli
later
stage
fiv
infect
although
sever
acut
stage
lesion
depend
virul
titer
infect
fiv
isol
lymph
node
abnorm
acut
stage
infect
includ
mixtur
follicular
hyperplasia
lymphoid
deplet
result
loss
lymph
node
architectur
medullari
plasmacytosi
lymphoid
hyperplasia
also
observ
lymphoid
tissu
includ
spleen
bone
marrow
mucosalassoci
lymphoid
tissu
sever
studi
shown
thymu
primari
target
earli
fiv
infect
patholog
chang
includ
thymic
atrophi
thymiti
medullari
bcell
hyperplasia
cortic
involut
lesion
gastrointestin
tract
frequent
observ
includ
sever
inflamm
necrosi
villou
atrophi
brain
lung
nonlymphoid
tissu
also
frequent
exhibit
patholog
chang
cn
lesion
consist
includ
gliosi
glial
nodul
perivascular
cellular
infiltr
less
frequent
includ
inflammatori
chang
associ
enceph
mening
neuron
abnorm
neuron
stress
neuron
satellitosi
giant
cell
format
frequent
lesion
siv
neuropatholog
rare
observ
histolog
examin
cn
tissu
fivinfect
cat
pulmonari
lesion
associ
fiv
infect
consist
inflammatori
infiltr
suggest
pneumonia
lymphoid
deplet
involut
within
multipl
lymphoid
tissu
domin
consist
find
tissu
harvest
cat
later
stage
fiv
infect
neoplast
lesion
includ
bcell
lymphoma
sarcoma
also
frequent
observ
later
stage
experiment
natur
fiv
infect
togeth
histolog
lesion
lymphoid
hyperplasia
frequent
character
bcell
hyperplasia
mix
sever
lymphoid
deplet
well
thymic
atrophi
sever
inflammatori
lesion
observ
gastrointestin
mucosa
mimic
patholog
chang
report
pathogen
siv
support
use
fiv
anim
examin
hiv
immunopathogenesi
mechan
either
fiv
tcell
deplet
dysfunct
vivo
like
involv
multipl
process
direct
cytolysi
viru
infect
virusspecif
immun
respons
indirect
strategi
includ
chronic
immun
activ
cellular
dysregul
inappropri
kill
uninfect
bystand
cell
vitro
syncytia
format
fivinfect
cell
well
document
due
viral
envelop
fusion
cellular
membran
associ
specif
cell
type
fiv
strain
program
cell
death
apoptosi
hypothes
one
sever
import
mechan
involv
immunopathogenesi
base
observ
apoptot
cell
virusinfect
cell
cultur
pbmc
lymphoid
thymic
tissu
isol
fivinfect
cat
recent
report
shown
bind
cell
surfac
chemokin
viru
receptor
fiv
tm
may
trigger
apoptosi
although
recent
report
suggest
fastnfa
receptor
pathway
may
import
fivinduc
apoptosi
mechan
fiv
use
pathway
apoptosi
well
understood
current
investig
second
probabl
pathway
fivinduc
apoptosi
involv
pathway
data
recent
report
indic
pbmc
lymph
node
lymphocyt
isol
fivinfect
cell
cultur
vitro
freshli
isol
fivinfect
cat
downregul
express
costimulatori
molecul
cell
instead
upregul
express
tcell
costimulatori
molecul
cell
surfac
molecul
express
activ
tcell
report
induc
anergi
activ
tcell
subset
furthermor
report
present
flow
cytometr
analys
verifi
induct
apoptosi
fivinfect
cultur
tcell
coexpress
cell
surfac
molecul
suggest
tcell
deplet
lymph
node
apoptosi
vivo
may
partial
result
chronic
tcell
interact
similarli
reduc
express
increas
express
observ
infect
hypothes
promot
immun
hyporespons
apoptosi
bind
costimulatori
molecul
although
mechan
fiv
infect
induc
increas
tcell
popul
vivo
well
understood
chronic
immun
activ
virusinfect
host
hypothes
one
possibl
etiolog
effect
observ
illustr
similar
fiv
diseas
potenti
valu
fiv
anim
model
vivo
studi
focus
mechan
immunopathogenesi
lentivirusinduc
acquir
immunodefici
emerg
cellular
humor
host
immun
respons
primari
infect
either
fiv
coincid
reduct
peak
peripher
blood
viru
load
respons
thought
import
control
viru
replic
acut
chronic
stage
infect
base
tcell
bcell
deplet
studi
involv
sivinfect
rhesu
macaqu
regardless
robust
virusspecif
immun
respons
infect
host
fail
elimin
viru
lead
prolong
clinic
latenc
eventu
immunolog
exhaust
subsequ
increas
viru
load
aid
current
factor
respons
inabl
host
respons
effect
clear
viru
primari
infect
well
understood
identif
factor
necessari
understand
immunopathogenesi
lentivir
infect
design
vaccin
capabl
induc
steril
immun
base
experiment
inocul
studi
antibodi
viral
protein
su
ca
first
appear
serum
usual
within
week
infect
quickli
follow
appear
antibodi
tm
gag
precursor
revers
transcriptas
lentivir
gag
protein
highli
express
immunogen
protein
fivinfect
cat
typic
exhibit
high
titer
antibodi
specif
viral
ca
four
bcell
epitop
map
fiv
ca
use
mous
monoclon
antibodi
howev
evid
caspecif
antibodi
function
either
fiv
clearanc
scarc
interestingli
recent
examin
serolog
respons
patient
undergo
prolong
antiretrovir
therapi
structur
treatment
interrupt
sti
show
kinet
caspecif
antibodi
respons
reveal
clear
differ
patient
immun
function
patient
exhibit
rapid
larg
increas
ca
antibodi
respons
also
experienc
significantli
decreas
viral
set
point
antibodi
specif
ca
shown
express
signific
antivir
activ
may
instead
reflect
enhanc
virusspecif
helper
activ
predict
capabl
host
antivir
immun
respons
similar
care
analys
fiv
gag
antibodi
respons
report
may
use
character
valu
respons
marker
aid
distinguish
protect
nonprotect
vaccineinduc
immun
respons
antibodi
bind
surfac
domain
envelop
thought
exhibit
viru
neutral
activ
accordingli
identif
envelop
bcell
epitop
critic
character
potenti
protect
host
immun
respons
multipl
report
identifi
region
su
carboxi
termin
su
highli
conserv
pid
locat
within
ectodomain
tm
major
immunodomin
domain
fiv
envelop
figur
four
linear
bcell
epitop
map
within
domain
su
su
epitop
local
within
domain
bcell
epitop
within
extracellular
tm
includ
pid
previous
discuss
second
domain
within
extracellular
membraneproxim
domain
tm
downstream
pid
third
domain
within
intracytoplasm
region
tm
contrast
tryptophanrich
motif
within
extracellular
domain
tm
function
viru
fusion
infect
found
immunogen
although
immunodomin
domain
fiv
env
determin
consist
shown
induc
antibodi
capabl
neutral
viru
vitro
determin
within
domain
includ
residu
also
shown
confer
broad
neutral
resist
bnr
primari
isol
passag
vivo
figur
remain
fiv
envelop
linear
epitop
map
bind
assay
like
inaccess
neutral
due
complex
oligomer
structur
extens
glycosyl
nativ
fiv
su
properti
share
su
express
neutral
epitop
tropism
determin
fiv
hypervari
domain
import
function
also
describ
domain
surfac
glycoprotein
also
signific
fiv
su
linear
epitop
capabl
induc
neutral
antibodi
locat
within
hypervari
region
envelop
may
chang
respons
select
pressur
vivo
importantli
epitop
encod
within
fiv
extracellular
membraneproxim
domain
tm
design
epitop
similarli
posit
epitop
recogn
extrem
potent
broadli
neutral
hiv
monoclon
antibodi
figur
although
felin
antisera
rais
fiv
tm
epitop
shown
exhibit
viru
neutral
activ
vitro
peptid
vaccin
base
epitop
shown
capabl
induc
partial
immun
fiv
challeng
observ
suggest
extracellular
membraneproxim
domain
may
encod
neutral
epitop
conserv
across
multipl
lentivirus
may
support
investig
tm
determin
fiv
vaccin
design
neutral
antibodi
emerg
host
peak
peripher
blood
viru
load
declin
primari
infect
thought
contribut
control
viru
load
replic
lentiviru
infect
includ
siv
fiv
control
infect
neutral
antibodi
also
base
tcell
bcell
deplet
studi
rhesu
macaqu
infect
either
siv
chimer
shiv
isol
report
describ
success
passiv
immun
either
neonat
kitten
neonat
macaqu
hyperimmun
serum
howev
despit
appar
success
observ
recent
therapeut
administr
exogen
highli
potent
neutral
antibodi
nonhuman
primat
anim
model
antibodi
induc
host
viru
infect
consist
ineffect
viru
clearanc
particularli
within
lymphoid
tissu
reservoir
furthermor
fiv
assay
system
use
establish
cell
line
rather
primari
lymphocyt
viru
infect
highli
passag
virus
compar
primari
strain
directli
isol
infect
cat
gener
significantli
differ
data
regard
neutral
activ
ident
serum
sampl
notabl
previou
studi
shown
fiv
primari
isol
resist
neutral
autolog
sera
especi
primari
pbmc
use
assay
infect
howev
recent
find
regard
neutral
antibodi
biolog
use
sophist
approach
analysi
antibodi
activ
trigger
renew
interest
support
investig
humor
immun
respons
viru
control
acut
chronic
infect
vaccin
design
similar
investig
seem
warrant
fiv
anim
model
especi
examin
antibodi
kinet
specif
associ
mucos
versu
parenter
rout
viru
exposur
investig
epitop
conserv
across
differ
viru
clade
vaccin
immunogen
strong
support
data
exist
tcellmedi
suppress
viru
load
patient
sivinfect
rhesu
macaqu
investig
fivspecif
cellular
immun
respons
previous
restrict
defici
key
felinespecif
reagent
includ
antibodi
specif
felin
cell
surfac
marker
cytokin
well
lack
knowledg
fiv
tcell
epitop
howev
recent
peptid
map
fivspecif
tcell
epitop
establish
assay
fivspecif
cytotox
tcell
ctl
activ
permit
character
cellular
immun
respons
induc
either
viru
infect
vaccin
furthermor
report
show
adopt
transfer
blood
cell
isol
fivvaccin
cat
induc
resist
mhcmatch
recipi
cat
fiv
challeng
infect
provid
evid
import
virusspecif
cellular
respons
viru
clearanc
longitudin
examin
cat
experiment
infect
fiv
reveal
virusspecif
ctl
activ
pbmc
within
week
infect
time
point
primari
infect
coincid
rise
viru
load
similar
report
ctl
emerg
infect
virusspecif
ctl
activ
also
detect
lymphocyt
isol
lymphoid
tissu
includ
system
peripher
lymph
node
spleen
primari
phase
infect
assay
ctl
activ
chronic
stage
infect
week
viru
exposur
demonstr
persist
cellular
respons
although
detect
antivir
ctl
consist
lymphoid
tissu
compar
peripher
blood
activ
specif
fiv
gag
rather
env
consist
observ
fivinfect
cat
describ
report
howev
current
describ
protocol
test
fivspecif
ctl
chromium
releas
assay
restrict
use
two
immunogen
provid
vaccinia
recombin
virus
one
express
gag
protein
deriv
isol
subtyp
express
env
protein
encod
fivpetaluma
also
subtyp
therefor
lower
envspecif
ctl
activ
may
partial
attribut
defici
assay
detect
due
variabl
within
recent
map
envencod
tcell
epitop
sinc
cat
describ
report
experiment
infect
fiv
isol
distinct
fivpetaluma
measur
ctl
respons
variabl
protein
env
requir
virusspecif
reagent
optim
assay
sensit
character
fivspecif
ctl
respons
also
call
assay
activ
viral
protein
includ
rt
rev
orfa
although
limit
map
env
tcell
epitop
previous
report
recent
report
describ
peptid
map
fiv
tcell
epitop
across
fiv
gene
use
felin
interferon
gamma
elispot
assay
newli
identifi
epitop
facilit
use
peptid
fiv
assay
character
fiv
respons
differ
fiv
isol
well
examin
occurr
fiv
ctl
epitop
escap
variant
welldescrib
trend
siv
hiv
infect
anoth
uniqu
test
fivspecif
ctl
activ
involv
assay
perforin
express
may
also
use
futur
examin
fivspecif
immun
respons
interestingli
b
low
tcell
subset
associ
antivir
activ
fivinfect
cat
actual
care
examin
topic
virusspecif
ctl
activ
cell
popul
also
describ
hiv
infect
initi
distinguish
expans
peripher
blood
primari
phase
fiv
infect
capac
suppress
viru
replic
cultur
pbmc
releas
solubl
factor
vitro
significantli
appear
cell
popul
correl
reduct
peak
pbmcassoci
viru
suggest
possibl
antivir
activ
vivo
well
vitro
fiv
infect
studi
confirm
expans
b
low
tcell
subset
also
reveal
express
lymphocyt
activ
adhes
marker
subset
howev
studi
also
show
conflict
data
issu
restrict
antivir
activ
b
low
subset
data
suggest
b
low
bsubset
capabl
noncytolyt
antivir
activ
lack
agreement
also
appar
among
studi
regard
correl
tcell
noncytolyt
antivir
activ
either
tcell
count
clinic
diseas
vivo
distribut
pattern
cell
subset
blood
lymphoid
tissu
persist
expans
b
low
subset
throughout
cours
viru
infect
recent
report
indic
antivir
activ
product
could
enhanc
induc
vitro
exposur
either
virusinfect
cell
cell
express
irrelev
antigen
induc
mitogen
activ
conflict
report
indic
addit
studi
use
standard
methodolog
need
precis
definit
tcell
antivir
activ
howev
data
gener
almost
studi
report
far
suggest
noncytolyt
antivir
activ
reminisc
still
undefin
secret
antivir
factor
caf
previous
describ
infect
noncytolyt
antivir
factor
associ
fiv
infect
although
clearli
defin
hypothes
associ
innat
immun
system
multipl
factor
propos
previou
report
repres
human
caf
includ
human
bchemokin
rant
alpha
defensin
protein
howev
meet
criteria
caf
definit
either
due
biochem
natur
exclus
express
tcell
observ
tcell
antivir
activ
fiv
infect
confirm
import
host
immun
respons
lentiviru
infect
provid
anoth
opportun
use
fiv
anim
model
assess
immunopathogenesi
safe
efficaci
vaccin
prevent
spread
hiv
essenti
arrest
spread
aid
epidem
studi
nonhuman
primat
siv
chimer
shiv
isol
demonstr
liveattenu
virus
highli
effect
howev
vaccin
maintain
low
level
pathogen
vaccin
trial
rhesu
macaqu
anim
model
describ
noninfecti
dna
vaccin
control
viremia
suppress
clinic
diseas
induc
steril
immun
sivshiv
infect
fiv
vaccin
research
develop
fairli
well
support
due
valu
anim
model
hiv
vaccin
develop
signific
fiv
natur
pathogen
cat
wide
varieti
vaccin
approach
examin
although
effort
concentr
particular
vaccin
method
includ
whole
kill
viru
wkv
base
vaccin
dna
vaccin
viral
protein
subunit
vaccin
commerci
fiv
vaccin
felovax
fiv
fort
dodg
anim
health
contain
whole
kill
virus
repres
two
distinct
fiv
subtyp
approv
usda
use
domest
pet
cat
popul
one
two
commerci
lentivir
vaccin
current
use
includ
live
attenu
eiav
vaccin
wide
use
china
howev
use
fiv
wkv
vaccin
still
wide
accept
due
signific
issu
includ
interfer
vaccineinduc
antivir
antibodi
commerci
fiv
diagnost
assay
potenti
vaccineinduc
enhanc
viru
infect
fiv
immun
studi
base
convent
wkv
fix
virusinfect
cell
fc
vaccin
produc
divers
array
experiment
find
vaccin
efficaci
differ
ident
fiv
wkvbase
vaccin
vari
greatli
like
due
modif
vaccin
inactiv
procedur
produc
cell
type
use
vaccin
schedul
vaccin
adjuv
vaccin
dose
rout
challeng
variabl
virul
subtyp
challeng
fiv
isol
wkvbase
vaccin
studi
report
complet
partial
protect
challeng
homolog
sometim
heterolog
fiv
isol
also
describ
vaccineinduc
enhanc
fiv
infect
interestingli
enhanc
challeng
viru
infect
frequent
associ
fc
vaccin
prepar
autolog
felin
lymphocyt
contrast
fc
wkv
vaccin
base
virusinfect
cell
line
proven
efficaci
although
protect
may
consider
reduc
challeng
either
heterolog
virul
fiv
isol
current
commerci
fiv
wkv
vaccin
compos
two
isol
includ
fivpetaluma
subtyp
fivshizuoka
subtyp
specif
broaden
virusspecif
immun
respons
demonstr
improv
protect
multipl
subtyp
compar
singl
subtyp
wkv
vaccin
use
fiv
wkv
vaccin
booster
prime
immun
recombin
canarypoxviru
alvac
base
fiv
vaccin
also
improv
protect
respons
challeng
isol
distinct
vaccin
strain
durat
wkv
fc
vaccineinduc
protect
anoth
concern
vaccin
studi
reveal
breakthrough
vaccineinduc
protect
year
vaccin
despit
booster
primari
immun
anoth
concern
relat
differ
wkv
fc
vaccineinduc
protect
observ
similar
challeng
virus
deliv
differ
rout
exposur
includ
parenter
mucos
deliveri
collect
find
suggest
wkv
vaccin
demonstr
signific
potenti
develop
lentiviru
vaccin
multipl
issu
includ
wkv
vaccineinduc
enhanc
still
requir
attent
achiev
optim
protect
conclus
regard
neutral
antibodi
immun
correl
vaccin
protect
frequent
vari
earli
report
describ
wkv
fc
fiv
vaccin
nonetheless
earli
studi
well
recent
report
present
find
suggest
correl
appear
viru
neutral
antibodi
wkv
fc
vaccineinduc
protect
wkv
fc
vaccin
also
induc
potent
cellular
immun
respons
thought
import
correl
protect
current
commerci
fiv
wkv
vaccin
contain
inactiv
whole
virus
subtyp
elicit
strong
cellular
respons
vaccin
strain
virus
moder
neutral
antibodi
activ
particularli
commerci
fort
dodg
vaccin
adjuv
supplement
human
fact
commerci
dual
subtyp
fiv
wkv
vaccin
administ
human
provid
broad
protect
homolog
heterolog
viru
challeng
contain
vivoderiv
fiv
inoculum
howev
actual
contribut
provid
cellular
humor
immun
respons
protect
induc
vaccin
approach
still
clear
may
ultim
requir
immun
cell
deplet
studi
determin
despit
report
fiv
wkv
fc
vaccin
efficaci
accept
vaccin
approach
veterinari
commun
restrict
concern
vaccin
antibodi
interfer
fiv
antibodybas
diagnost
furthermor
explor
wkv
vaccin
siv
shiv
anim
model
extrem
limit
discourag
earli
studi
show
siv
wkv
vaccineinduc
protect
result
immun
respons
cellular
antigen
vaccin
prepar
rather
viral
antigen
howev
renew
enthusiasm
vaccin
induc
strong
neutral
antibodi
respons
lent
increas
support
multipl
modal
vaccin
approach
includ
wkv
compon
inclus
wkv
vaccin
compon
expect
enhanc
broaden
virusspecif
humor
immun
respons
induc
vaccin
compon
live
viral
vector
dna
sizabl
bodi
data
alreadi
gener
fiv
wkv
fc
fiv
lend
strong
support
use
felin
anim
model
investig
wkv
fc
vaccin
approach
variou
fiv
subunit
vaccin
approach
test
includ
su
primarili
epitop
tm
gag
peptid
recombin
su
protein
gener
bacteri
express
plasmid
administ
singl
immunogen
combin
recombin
su
protein
express
vaccinia
baculoviru
vector
system
immunoaffinitypurifi
su
fivinfect
cell
lysat
absenc
protect
fiv
challeng
observ
mani
frequent
highli
immunogen
subunit
approach
recapitul
find
report
subunit
vaccin
approach
nonhuman
primat
model
howev
partial
protect
challeng
infect
reveal
report
describ
immun
either
immunoaffinitypurifi
su
su
protein
conjug
autolog
erythrocyt
via
biotinavidinbiotin
bridg
although
immun
correl
protect
determin
describ
section
immun
respons
fiv
peptid
vaccin
base
extracellular
epitop
similarli
posit
highli
neutral
epitop
also
shown
capabl
induc
partial
immun
fiv
challeng
vaccineinduc
enhanc
fiv
challeng
viru
infect
also
observ
subunit
approach
consist
coimmun
bacteri
express
fulllength
envelop
protein
either
su
sutm
vaccinia
recombin
protein
howev
coinocul
recombin
su
protein
plasmid
express
vector
encod
fiv
nc
protein
abrog
vaccineinduc
enhanc
challeng
infect
observ
vaccin
recombin
su
alon
actual
improv
vaccin
efficaci
anoth
studi
loss
vaccineinduc
enhanc
increas
vaccin
efficaci
associ
coinocul
nc
express
plasmid
recombin
su
hypothes
result
plasmid
dna
adjuv
effect
base
alter
cytokin
express
profil
absenc
fiv
ncspecif
immun
respons
associ
approach
togeth
data
support
use
vaccin
consist
singl
viral
protein
subunit
instead
find
suggest
fiv
may
provid
anoth
vaccin
model
test
peptid
encod
broadli
reactiv
neutral
epitop
compon
multipl
modal
vaccin
also
includ
immunogen
induct
cellular
respons
balanc
vaccin
approach
current
interest
vaccin
design
assess
vaccin
approach
includ
dna
vaccin
attenu
viru
vaccin
live
attenu
viral
bacteri
vector
express
fiv
antigen
still
somewhat
limit
time
fiv
dna
vaccin
approach
base
delet
mutant
fiv
proviru
plasmid
shown
consider
efficaci
challeng
less
virul
fiv
isol
dna
vaccin
includ
either
defect
provirus
su
tm
express
cassett
along
felin
cytokin
express
vector
shown
particular
promis
limit
studi
extrem
low
absent
humor
immun
respons
observ
fiv
dna
vaccin
may
partial
result
failur
incorpor
codon
optim
viral
structur
gene
encod
vaccin
plasmid
process
found
critic
improv
immunogen
dna
vaccin
coexpress
viral
rev
protein
dna
vaccin
efficaci
observ
despit
low
antibodi
respons
may
attribut
measur
strong
virusspecif
ctl
respons
despit
lack
clear
correl
measur
ctl
activ
dna
vaccineinduc
protect
unfortun
dna
vaccineinduc
protect
proven
reduc
neglig
pathogen
isol
moreov
dna
vaccin
encod
envelop
gene
use
without
cytokin
adjuv
associ
enhanc
challeng
viru
infect
mix
result
regard
efficaci
report
fiv
vaccin
util
either
live
viral
bacteri
vector
immun
cat
replicationdefect
adenoviru
type
express
fiv
env
poorli
immunogen
fail
induc
protect
fiv
challeng
vaccin
compos
venezuelan
equin
enceph
vee
viru
replicon
particl
engin
express
fiv
matrixcapsid
region
gag
full
length
env
also
fail
induc
protect
fiv
challeng
although
vaccin
elicit
humor
cellular
respons
combin
vaccin
use
prime
inocul
felin
herp
viru
fhv
vector
express
fiv
gag
gene
fhv
vector
express
fiv
env
booster
inocul
fiv
fc
vaccin
also
fail
protect
immun
cat
fiv
challeng
infect
contrast
partial
protect
fiv
challeng
observ
cat
immun
live
attenu
salmonella
typhimuriaum
aroa
strain
express
fiv
ca
truncat
su
encod
hypervari
region
although
correl
protect
defin
partial
protect
challeng
also
observ
vaccin
cat
recombin
canarypoxviru
alvac
base
fiv
vaccin
use
alon
combin
fiv
fc
vaccin
furthermor
singl
oral
immun
cat
live
recombin
listeria
monocytogen
strain
express
fiv
gag
deliv
fiv
truncat
envexpress
plasmid
found
confer
protect
reduct
viru
load
virusinduc
diseas
fiv
challeng
limit
number
fiv
vaccin
studi
util
live
viral
vector
surpris
given
interest
success
multipl
modal
vaccin
consist
live
recombin
viral
vector
dna
express
plasmid
recent
observ
sivshiv
anim
model
attenu
live
viru
vaccin
extens
examin
sivshiv
anim
model
due
consist
efficaci
shown
virus
induc
protect
challeng
highli
pathogen
siv
shiv
isol
wide
use
vaccin
base
attenu
strain
equin
lentiviru
eiav
protect
million
hors
donkey
past
year
china
studi
describ
efficaci
molecularli
clone
attenu
eiav
caev
vaccin
virus
also
report
examin
attenu
fiv
vaccin
limit
shown
approach
also
effect
felin
aid
anim
model
fivpetaluma
viru
variant
use
commerci
fiv
wkv
vaccin
recent
shown
establish
lowlevel
infect
cat
without
induct
appar
fivassoci
diseas
furthermor
infect
attenu
fivpetaluma
variant
protect
infect
differ
pathogen
fiv
isol
fiv
although
subtyp
complet
protect
confer
attenu
fiv
fiv
deliv
intraperiton
rout
partial
protect
demonstr
challeng
mucos
rout
complet
protect
also
impart
wildtyp
fiv
challeng
inocul
cat
infecti
molecularli
clone
fiv
delet
mutant
includ
ltr
mutant
encod
delet
site
vifdelet
proviru
fivdvif
administ
dna
vaccin
lastli
superinfect
domest
cat
either
nonpathogen
lion
puma
nondomest
felin
lentivirus
shown
confer
resist
infect
pathogen
domest
fiv
immun
correl
appar
attenu
fiv
vaccin
studi
fact
substanti
genet
variat
observ
domest
nondomest
felin
lentivirus
argu
initi
control
challeng
viru
infect
driven
epitopespecif
immun
respons
instead
suggest
current
undetermin
resist
factor
mechan
possibl
associ
innat
immun
system
import
limit
attenu
lentivir
vaccin
concern
longterm
safeti
demonstr
experi
perform
ruprecht
cowork
show
siv
nef
delet
mutant
may
caus
fatal
aidslik
diseas
newborn
macaqu
may
becom
pathogen
longterm
infect
adult
macaqu
regardless
whether
attenu
lentiviru
vaccin
ever
safe
enough
gener
use
examin
virus
anim
model
system
includ
fiv
offer
import
opportun
identifi
fulli
character
immun
respons
undefin
host
resist
factor
confer
protect
pathogen
viru
infect
diseas
fiv
vaccin
develop
face
critic
issu
similar
ident
face
vaccin
character
immun
correl
protect
immun
fiv
vaccin
approach
examin
far
elus
situat
common
lentiviru
vaccin
includ
siv
shiv
must
address
success
vaccin
design
futur
vaccineinduc
enhanc
pathogen
viru
challeng
consist
observ
fiv
eiav
vaccin
approach
involv
either
wkv
fc
protein
subunitspeptid
fiv
thought
result
enhanc
antibodi
might
specif
epitop
within
env
hypervari
region
pid
epitop
howev
vaccin
use
recombin
env
protein
region
delet
shown
remain
capabl
induc
enhanc
challeng
infect
occurr
fiv
dna
vaccineinduc
enhanc
challeng
viru
infect
despit
neglig
antibodi
respons
also
suggest
mechan
enhanc
antibodi
lymphoid
activ
recent
report
describ
enhanc
challeng
viru
infect
vaccin
rhesu
macaqu
attenu
recombin
varicellazost
viru
vaccin
express
siv
env
vaccineassoci
enhanc
studi
correl
appear
robust
anamnest
virusspecif
prolif
respons
absenc
strong
respons
suggest
immun
activ
may
play
role
vaccineinduc
enhanc
along
cellular
respons
skew
tcell
find
suggest
major
concern
clinic
test
vaccin
less
optim
respons
alreadi
predict
valid
use
fiv
anim
model
character
potenti
devast
complic
hiv
vaccin
use
third
issu
import
futur
current
commerci
fiv
vaccin
design
well
futur
commerci
vaccin
concern
interfer
vaccineinduc
antibodi
fiv
diagnost
lentiviru
diagnost
assay
system
util
seroposit
marker
viru
infect
pbmc
viru
isol
plasma
viral
rna
detect
system
use
pcr
although
specif
suffici
sensit
detect
viru
infect
current
feasibl
routin
diagnost
assay
futur
vaccin
design
eventu
need
address
issu
fiv
anim
model
may
prove
use
rel
soon
initi
isol
character
fiv
consider
effort
focus
character
lentiviru
anim
model
antivir
therapi
studi
encourag
similar
fiv
rt
amino
acid
sequenc
structur
physic
properti
catalyt
activ
suscept
multipl
nucleosid
analog
includ
azt
adenin
pmea
r
r
pmpdap
discuss
earlier
chapter
convers
fiv
proven
rel
resist
therapi
includ
nonnucleosid
rt
inhibitor
proteas
inhibitor
use
highli
activ
antiretrovir
therapi
haart
protocol
patient
nevertheless
ongo
studi
evalu
proteas
inhibitor
vivo
show
activ
proteas
multipl
lentivirus
vitro
well
drug
target
lentivir
tm
fusion
domain
conserv
across
differ
lentivirus
identif
compound
import
design
efficaci
haart
protocol
fiv
infect
continu
develop
fiv
model
antivir
drug
therapi
examin
fiv
suscept
azt
vitro
result
first
descript
emerg
aztresist
lentiviru
viru
passag
cell
cultur
led
rigor
examin
multipl
drugresist
fiv
rt
mutant
aris
vitro
although
fiv
resist
azt
map
homolog
residu
within
aztresist
rt
mutant
fiv
share
similar
determin
ymdd
activ
site
rt
palm
subdomain
suscept
nucleosid
analog
accordingli
mettothr
mutat
ymdd
motif
rt
observ
mutant
fiv
studi
assess
drugresist
fiv
mutant
vivo
reveal
attenu
aztresist
fiv
inocul
cat
find
recommend
potenti
use
model
character
pathogenesi
fiv
variant
resist
drug
target
domain
conserv
lentivir
enzymat
protein
examin
fiv
suscept
nucleosid
analog
azt
pmea
r
pmpdap
vitro
complement
varieti
vivo
studi
illustr
valu
anim
model
antivir
drug
develop
assess
drug
efficaci
studi
test
merit
azt
monotherapi
either
reduc
viru
load
improv
tcell
ratio
clinic
statu
experiment
primari
infect
chronic
natur
infect
fiv
produc
somewhat
mix
result
altogeth
howev
investig
reveal
fairli
limit
efficaci
azt
use
singl
therapeut
regimen
fiv
infect
previous
found
infect
frequent
report
side
effect
anemia
also
observ
human
patient
furthermor
singl
report
examin
combin
therapi
azt
cat
either
acut
chronic
infect
fiv
describ
slightli
improv
efficaci
compar
azt
treatment
alon
contrast
nucleosid
analog
pmea
deriv
r
pmpdap
proven
efficaci
antivir
therapi
fiv
infect
vitro
vivo
significantli
reduc
viru
load
improv
tcell
ratio
combin
therapi
consist
azt
third
nucleosid
analog
abacavir
also
block
fiv
replic
synergist
manner
vitro
observ
suggest
drug
combin
combin
includ
pmea
may
warrant
futur
assess
haart
protocol
use
fiv
anim
model
shortag
proteas
inhibitor
effect
fiv
replic
due
differ
substrat
specif
display
fiv
pr
pr
hamper
use
fiv
anim
analysi
combin
drug
protocol
use
haart
protocol
patient
howev
attempt
identifi
proteas
inhibitor
univers
activ
multipl
lentiviru
pr
reveal
statinebas
inhibitor
competit
inhibitor
identifi
capabl
inhibit
pr
express
siv
fiv
interestingli
comparison
crystal
structur
fiv
pr
pr
complex
reveal
differ
posit
flap
fiv
pr
pr
wherea
complex
fiv
pr
pr
inhibitor
nearli
ident
conform
recent
report
shown
inhibit
fiv
replic
activ
proteas
inhibitorresist
mutant
vitro
furthermor
treatment
fivinfect
cat
reduc
viru
load
diseas
includ
clinic
neurolog
dysfunct
sever
acut
phase
immunodefici
find
support
test
combin
drug
protocol
fiv
infect
cell
cultur
system
vivo
assess
combin
protocol
may
particularli
warrant
test
propos
hypothesi
therapi
compound
broadli
reactiv
proteas
multipl
lentivirus
less
like
associ
emerg
proteas
inhibitorresist
viru
mutant
vivo
recent
preliminari
studi
also
describ
test
synthet
peptid
target
determin
within
fiv
tm
ectodomain
heptad
repeat
domain
membraneproxim
tryptophanrich
region
figur
antivir
therapeut
previou
studi
show
peptid
deriv
region
potent
inhibitor
infect
function
block
virusmedi
cell
fusion
similarli
membraneproxim
tryptophanrich
region
immedi
downstream
within
tm
ectodomain
also
shown
import
virusinduc
fusion
infect
fiv
test
combin
fiv
therapi
includ
nucleosid
analog
proteas
inhibitor
env
peptid
inhibitor
proven
activ
fiv
yet
report
look
promis
develop
fiv
model
haart
therapi
variou
antivir
approach
shown
activ
fiv
replic
either
vitro
vivo
examin
limit
fashion
strategi
previous
shown
success
target
fiv
rev
regulatori
system
vitro
includ
ribozym
direct
fiv
rre
element
small
molecul
intervent
use
block
format
hypusin
requir
cellular
factor
requir
rev
function
cytokin
cellular
growth
factor
includ
recombin
human
human
interferonomega
human
interferontau
recombin
human
gmcsf
recombin
human
insulin
growth
demonstr
limit
success
treatment
fiv
infect
either
cell
cultur
system
infect
cat
howev
cytokin
adjunct
therapi
haart
therapi
current
evalu
patient
may
worthi
similar
examin
fiv
model
mechan
may
experiment
character
cytokin
may
use
immun
reconstitut
therapeut
activ
express
latent
reservoir
virus
subsequ
elimin
antivir
drug
conclus
anim
model
fiv
siv
provid
opportun
examin
tissu
cell
subset
reservoir
viru
host
undergo
haart
therapi
report
patient
importantli
character
viral
mechan
persist
within
reservoir
advanc
character
fiv
molecular
virolog
facilit
develop
fiv
vector
vehicl
gene
transfer
divid
nondivid
cell
fiv
vector
develop
equal
contribut
significantli
bodi
knowledg
regard
viral
determin
fiv
gene
express
viru
packag
integr
lentivirus
provid
uniqu
vector
system
allow
reliabl
integr
foreign
gene
chromosom
dna
nondivid
cell
although
cumul
data
gener
hivbas
vector
suggest
safe
effect
primat
lentiviru
vector
possibl
concern
clinic
use
gene
vector
deriv
pathogen
human
retroviru
may
restrict
use
vector
fiv
provid
first
nonprim
lentiviru
vector
system
capabl
gene
transfer
effici
compar
observ
hivbas
vector
develop
lentiviru
vector
base
fiv
receiv
continu
support
due
appar
lack
fiv
replic
compet
human
cell
result
restrict
fiv
ltr
promot
activ
although
cell
cultureadapt
variant
fiv
capabl
util
human
chemokin
receptor
infect
human
cell
fiv
ltrdirect
gene
express
viru
product
abrog
human
cell
lack
crossreact
fiv
protein
hiv
anoth
potenti
advantag
use
fivbas
vector
discuss
fiv
virion
structur
genom
organ
typic
lentivir
genom
except
absenc
specif
accessori
regulatori
gene
vpr
vpu
nef
tat
presenc
polencod
dutpas
less
complic
fiv
genom
provid
anoth
advantag
use
vector
system
fiv
vector
system
infect
human
primari
cell
type
broad
array
tissu
includ
brain
eye
airway
hematopoiet
system
liver
muscl
pancrea
factor
promot
enthusiasm
fiv
vector
system
gene
therapi
human
diseas
first
fiv
vector
describ
deriv
fiv
molecular
clone
document
fivbas
vector
capabl
transduc
nondivid
human
cell
subsequ
studi
report
research
group
describ
biolog
cell
tropism
similar
modifi
fiv
vector
system
also
base
fiv
fiv
vector
system
describ
date
use
three
plasmid
transfer
vector
encod
gene
interest
packag
vector
express
structur
enzymat
gene
plasmid
express
vesicular
stomat
viru
vsv
g
envelop
protein
pseudotyp
vector
particl
chimer
fiv
ltr
compos
human
cytomegaloviru
hcmv
immedi
earli
gene
promot
replac
fiv
element
fuse
ltr
domain
found
fiv
transfer
vector
necessari
fiv
vector
product
human
cell
state
earlier
studi
focus
optim
fiv
vector
system
map
specif
replic
domain
includ
encapsid
determin
central
polypurin
tract
central
termin
sequenc
gener
central
dna
flap
preintegr
complex
data
studi
reveal
diverg
sequenc
fiv
cptt
fiv
ptt
also
show
fiv
cptt
ptt
entir
purin
find
uncov
differ
fiv
revers
transcript
incorpor
fiv
vector
design
vector
optim
studi
also
character
class
fiv
integras
mutant
prevent
integras
reaction
perturb
gagpol
function
integras
mutant
may
incorpor
preclin
gene
therapi
studi
anim
provid
control
vector
identifi
tissu
requir
vector
integr
gene
express
final
fiv
vector
modifi
delet
noncod
nonstructur
fiv
sequenc
well
specif
gag
sequenc
construct
minim
vector
reduc
cytotox
yet
effici
gene
transfer
continu
fiv
vector
design
studi
contribut
understand
fiv
life
cycl
fiv
molecular
virolog
well
facilit
develop
optim
lentivir
vector
system
addit
studi
also
requir
fulli
character
compar
rel
effici
well
biosafeti
fiv
primat
lentiviru
vector
initi
observ
infect
nondomest
cat
felin
lentiviru
subsequ
confirm
multipl
report
reveal
either
virolog
serolog
evid
infect
captiv
freerang
popul
sever
nondomest
felin
speci
speciesspecif
felin
lentiviru
isol
sinc
character
lion
fivpl
leopard
fivppa
pumascourgar
fivpco
palla
cat
fivoma
nondomest
felin
lentiviru
infect
freerang
nondomest
felid
worldwid
includ
lion
leopard
popul
within
africa
cougar
popul
southern
western
unit
state
canada
south
america
cheetah
africa
palla
cat
central
asia
interestingli
preval
felin
lentiviru
infect
specif
nondomest
cat
popul
includ
lion
serengeti
nation
park
ngorongoro
crater
east
africa
kruger
nation
park
south
africa
cougar
within
snowi
mountain
rage
wyom
quit
high
rang
cougar
lion
despit
evid
endem
infect
freerang
lion
cougar
popul
overt
diseas
associ
lentiviru
infect
popul
appar
lack
virul
along
signific
genet
divers
observ
among
felin
lentivirus
suggest
fivpco
fivpl
ancient
virus
adapt
host
may
compar
african
siv
isol
similarli
nonpathogen
natur
host
genom
divers
character
molecularli
clone
fivoma
provir
genom
reveal
genom
organ
similar
domest
cat
fiv
isol
howev
current
knowledg
genom
divers
nondomest
fiv
isol
base
primarili
phylogenet
analys
focus
viral
sequenc
gener
endem
fivpleand
fivpcoinfect
cat
popul
although
lentivirus
infect
nondomest
cat
clearli
relat
domest
cat
fiv
comparison
amino
acid
nucleotid
sequenc
deriv
highli
conserv
pol
gene
nondomest
lion
cougar
palla
cat
domest
felin
fiv
isol
reveal
consider
variat
rang
differ
nucleotid
amino
acid
data
indic
diverg
domest
nondomest
cat
lentivir
genom
similar
observ
furthermor
signific
genom
divers
report
cougar
fivpco
isol
gather
north
south
america
defin
two
princip
clade
diverg
subclad
nondomest
fiv
genet
diverg
measur
two
fivpco
clade
similar
divers
distinguish
domest
cat
fiv
fivpl
isol
similarli
analys
fivpl
isol
lion
popul
within
serengeti
reserv
ngorongoro
crater
southeastern
africa
identifi
three
phylogenet
clade
exhibit
genet
divers
also
similar
separ
domest
cat
fiv
fivpco
sequenc
divers
within
conserv
pol
gene
deriv
fivpco
fivpl
isol
greater
report
pol
sequenc
avail
domest
cat
fiv
fact
pol
gene
variat
similar
divers
measur
variabl
env
gene
use
defin
uniqu
domest
cat
fiv
clade
find
provid
addit
support
theori
nondomest
felin
lentivirus
ancient
virus
exist
within
cougar
lion
speci
much
longer
fiv
domest
cat
addit
find
phylogenet
analys
endem
fivpcoand
fivpleinfect
cat
popul
includ
evid
vertic
transmiss
pco
possibl
coinfect
differ
subtyp
within
singl
host
pco
ple
recent
report
examin
larg
freerang
lion
popul
includ
pride
within
serengeti
nation
park
reveal
presenc
three
fivpl
subtyp
wide
dispers
within
popul
infect
three
fivpl
subtyp
within
pride
possibl
within
host
also
observ
furthermor
high
incid
coinfect
two
three
fivpl
subtyp
within
individu
anim
report
although
altern
possibl
infect
subtyperecombin
virus
rule
signific
genom
diverg
differ
fivpl
subtyp
notabl
subtyp
c
two
subtyp
b
also
observ
popul
lion
monophylet
cluster
fivpl
sequenc
observ
one
pride
studi
find
describ
lion
popul
within
serengeti
nation
park
contrast
gener
studi
smaller
popul
wild
cougar
locat
mountain
rang
southeast
wyom
anim
support
overal
fivpco
preval
rate
remark
rate
infect
adult
anim
although
analysi
pol
env
sequenc
confirm
presenc
two
distinct
fivpco
lineag
within
infect
cougar
popul
sequenc
divers
lineag
low
evid
coinfect
singl
host
virus
distinct
lineag
found
importantli
investig
evolut
fivpco
pol
env
sequenc
within
cougar
popul
time
reveal
mean
rate
per
year
rate
consider
less
rate
per
year
report
hiv
collect
observ
gener
far
phylogenet
analys
nondomest
fiv
isol
suggest
lentiviru
infect
provid
uniqu
opportun
evalu
viru
dynam
viral
sequenc
evolut
natur
host
nonpathogen
lentiviru
extent
genet
diverg
describ
far
domest
nondomest
felin
fiv
isol
would
suggest
infect
replic
nondomest
isol
may
possibl
domest
cat
primari
lymphocyt
isol
domest
cat
report
vitro
replic
properti
nondomest
felin
lentivirus
scarc
restrict
inabl
nondomest
fiv
isol
cougar
fivpco
replic
domest
cat
primari
lymphocyt
howev
nondomest
fiv
isol
includ
fivpl
fivoma
shown
replic
domest
cat
lymphocyt
felin
cell
line
includ
crfk
cell
fivoma
felin
lymphoid
cell
line
cell
fivpl
fivpco
also
shown
replic
cell
although
character
receptor
usag
nondomest
felin
lentivirus
yet
report
current
find
vitro
growth
properti
suggest
nondomest
fiv
isol
may
also
capabl
infect
replic
vivo
domest
cat
rare
isol
case
natur
occur
crossspeci
transmiss
domest
cat
fiv
nondomest
cat
report
involv
cougar
wildcaught
tsushima
cat
belong
subspeci
leopard
cat
locat
japan
experiment
transmiss
studi
also
confirm
infect
fivpco
fivpl
domest
cat
reveal
establish
persist
fivpl
viral
infect
possibl
absenc
fivassoci
diseas
moreov
prior
infect
domest
cat
either
fivpco
fivpl
appear
impart
resist
challeng
pathogen
domest
cat
fiv
base
lower
challeng
viru
load
higher
count
measur
fivpcoand
fivpleinfect
domest
cat
compar
naiv
cat
exposur
domest
cat
fiv
addit
studi
rigor
measur
viru
load
care
examin
viral
immunopathogenesi
extend
time
period
need
character
nondomest
felin
lentiviru
infect
domest
cat
model
hiv
infect
signific
progress
made
develop
antivir
drug
regimen
although
complet
elimin
viru
host
full
restor
immunocompet
still
possibl
howev
commerci
safe
efficaci
vaccin
still
avail
unlik
near
futur
despit
exhaust
effort
vaccin
develop
began
year
ago
immedi
initi
character
sever
seriou
issu
must
resolv
futur
vaccin
success
includ
identif
immun
correl
protect
either
lentiviru
infect
virusassoci
diseas
appar
difficulti
address
question
predict
sinc
viru
elimin
observ
natur
infect
immunodeficiencyinduc
lentivirus
even
strong
virusspecif
cellular
humor
immun
respons
detect
infect
host
vaccineinduc
protect
pathogen
challeng
difficult
achiev
siv
fiv
anim
model
observ
inconsist
addit
complic
present
specter
vaccineinduc
immun
respons
prove
detriment
rather
protect
report
fiv
recent
siv
anim
model
complic
viru
strain
divers
bare
address
vaccin
design
anim
model
sure
pose
major
complic
vaccin
success
futur
success
resolut
obstacl
vaccin
develop
particularli
lack
understand
vaccin
attenu
virus
sometim
protect
absolut
requir
continu
examin
viral
pathogenesi
host
immun
respons
anim
model
includ
nonhuman
primat
nonprim
lentiviru
anim
model
elucid
pathogen
mechan
use
immunodeficiencyinduc
lentivirus
earliest
stage
viru
exposur
virushost
interact
critic
design
vaccin
potenti
steril
immun
goal
possibl
similarli
far
precis
understand
viral
mechan
immunodefici
also
necessari
design
therapi
immun
reconstitut
acut
chronic
host
gain
experiment
anim
model
studi
signific
progress
character
fiv
infect
accomplish
past
year
especi
regard
molecular
character
viral
protein
fiv
receptor
usag
viru
tropism
local
vivo
progress
develop
fiv
vector
gene
therapi
also
accomplish
contribut
consider
molecular
character
fiv
continu
effort
fiv
vaccin
broadbas
antivir
therapeut
develop
demonstr
strong
potenti
fiv
model
investig
novel
vaccin
approach
antivir
drug
lastli
similar
observ
host
cell
target
viru
infect
immunodefici
associ
fiv
hiv
infect
vivo
offer
strong
support
use
anim
model
crucial
studi
focus
mechan
immunopathogenesi
lentivirusinduc
acquir
immunodefici
